[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 444
1. Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, Meadows AT, Hutchinson R, Dreyer ZE, Robison LL, Mertens AC: Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol; 2005 Jun 1;23(16):3733-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • NMSC patients were defined by a history of basal cell or squamous cell carcinoma of the skin after primary malignancy treatment.
  • RESULTS: Among the 13,132 eligible CCSS participants, 213 have reported NMSC; 99 patients (46%) have had multiple occurrences.
  • [MeSH-major] Carcinoma, Basal Cell / mortality. Carcinoma, Squamous Cell / mortality. Skin Neoplasms / mortality. Survivors

  • Genetic Alliance. consumer health - Childhood Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15923570.001).
  • [ISSN] 0732-183X
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


2. Herzog Neto G, Sebastiá R, Viana GA, Machado F: [Eyelid reconstruction with Fricke's flap: report of two cases]. Arq Bras Oftalmol; 2006 Jan-Feb;69(1):123-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Skin cancer is the most common neoplasm in human beings and among them, basal cell carcinoma is the most prevalent.
  • The histopathological test diagnosed basal cell carcinoma, with clear margins.
  • The second patient was a female, 68 years old, who had an accident with multiple scars at the left side of her face two years before.
  • The histopathological test diagnosed basal cell carcinoma, with clear margins.
  • [MeSH-major] Blepharoplasty / methods. Carcinoma, Basal Cell / surgery. Eyelid Neoplasms / surgery. Skin Neoplasms / surgery. Surgical Flaps

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16491248.001).
  • [ISSN] 0004-2749
  • [Journal-full-title] Arquivos brasileiros de oftalmologia
  • [ISO-abbreviation] Arq Bras Oftalmol
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


3. Wallin JL, Tanna N, Misra S, Puri PK, Sadeghi N: Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome. Am J Otolaryngol; 2007 Sep-Oct;28(5):360-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome.
  • BACKGROUND: Nevoid basal cell carcinoma syndrome (NBCCS) is associated with multiple basal cell carcinomas, odontogenic cysts, craniofacial anomalies, and childhood medulloblastomas.
  • METHODS: We present a 19-year-old man with NBCCS who presented with a sinonasal carcinoma 17 years after receiving craniospinal irradiation for treatment of medulloblastoma.
  • [MeSH-major] Basal Cell Nevus Syndrome / complications. Neoplasms, Radiation-Induced / surgery. Paranasal Sinus Neoplasms / etiology. Paranasal Sinus Neoplasms / surgery. Radiotherapy / adverse effects


Advertisement
4. Hellani A, Baghdadi H, Dabbour N, Almassri N, Abu-Amero KK: A novel PTCH1 germline mutation distinguishes basal cell carcinoma from basaloid follicular hamartoma: a case report. J Med Case Rep; 2009;3:52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel PTCH1 germline mutation distinguishes basal cell carcinoma from basaloid follicular hamartoma: a case report.
  • INTRODUCTION: Nevoid basal cell carcinoma syndrome is a rare autosomal dominant disorder characterized by numerous basal cell carcinomas, odontogenic keratocysts of the jaws and developmental defects.
  • CASE PRESENTATION: A 15-year-old boy presented to our dental clinic with multiple jaw cysts.
  • Examination of the jaw cysts revealed many keratinizing cysts without granular cell layers a finding that raised the suspicion of nevoid basal cell carcinoma.
  • These features make it difficult to differentiate between nevoid basal cell carcinoma and basaloid follicular hamartoma, especially the presence of these findings on a non-hairy area.
  • BCL-2 staining was positive in the periphery of the basaloid proliferation, which is typical of basaloid follicular hamartoma, and not in a diffuse pattern, which is typical of nevoid basal cell carcinoma.
  • Since histology was equivocal and palmoplantar pits are seen in both basaloid follicular hamartoma and nevoid basal cell carcinoma, molecular genetic investigation was necessary to differentiate between the two potential diagnoses.
  • CONCLUSION: Screening the PTCH1 gene for mutations helped to differentiate between basaloid follicular hamartoma and nevoid basal cell carcinoma and confirmed the diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cutan Pathol. 2008 May;35(5):477-83 [18399809.001]
  • [Cites] Oral Dis. 2008 Mar;14(2):174-9 [18302678.001]
  • [Cites] Hum Mutat. 2006 Mar;27(3):215-9 [16419085.001]
  • [Cites] Development. 1998 Aug;125(15):2803-11 [9655803.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):757-62 [11257109.001]
  • [Cites] Nat Genet. 1996 Sep;14(1):78-81 [8782823.001]
  • [Cites] Dermatol Clin. 1995 Jan;13(1):113-25 [7712637.001]
  • [Cites] Hum Mutat. 2003 Jun;21(6):577-81 [12754702.001]
  • [Cites] Nature. 1996 Nov 14;384(6605):129-34 [8906787.001]
  • (PMID = 19203369.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2642855
  •  go-up   go-down


5. Caty V, Liu Y, Viau G, Bissonnette R: Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice. Br J Dermatol; 2006 Apr;154(4):740-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.
  • The PTCH gene plays a central role in the genesis of basal cell carcinoma (BCC).
  • OBJECTIVES: The aim of this study was to explore the ability of multiple large surface MAL-PDT to prevent BCC, using the PTCH heterozygous mouse as a model.
  • [MeSH-major] Aminolevulinic Acid / analogs & derivatives. Carcinoma, Basal Cell / prevention & control. Photochemotherapy / methods. Photosensitizing Agents / therapeutic use. Skin Neoplasms / prevention & control
  • [MeSH-minor] Animals. Female. Genetic Predisposition to Disease. Heterozygote. Mice. Mice, Transgenic. Neoplasms, Radiation-Induced / etiology. Neoplasms, Radiation-Induced / genetics. Neoplasms, Radiation-Induced / prevention & control. Receptors, Cell Surface / genetics. Ultraviolet Rays / adverse effects

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16536820.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 0 / Receptors, Cell Surface; 0 / methyl 5-aminolevulinate; 0 / patched receptors; 88755TAZ87 / Aminolevulinic Acid
  •  go-up   go-down


6. Lear W, Mittmann N, Barnes E, Breen D, Murray C: Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg; 2008 Mar-Apr;12(2):82-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
  • BACKGROUND: Basal cell carcinoma (BCC) is the most common human malignancy and accounts for over 60,000 new cases of cancer in Canada annually.
  • The costs were significantly higher for patients with multiple tumors with both modalities (p = .02 for both).
  • [MeSH-major] Carcinoma, Basal Cell / economics. Cost of Illness. Facial Neoplasms / economics. Mohs Surgery / economics. Skin Neoplasms / economics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18346405.001).
  • [ISSN] 1203-4754
  • [Journal-full-title] Journal of cutaneous medicine and surgery
  • [ISO-abbreviation] J Cutan Med Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev; 2005 Aug;26(5):662-87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Physiological and pharmacological actions of 1,25-(OH)(2)D(3) in various systems, along with the detection of VDR in target cells, have indicated potential therapeutic applications of VDR ligands in inflammation (rheumatoid arthritis, psoriatic arthritis), dermatological indications (psoriasis, actinic keratosis, seborrheic dermatitis, photoaging), osteoporosis (postmenopausal and steroid-induced osteoporosis), cancers (prostate, colon, breast, myelodysplasia, leukemia, head and neck squamous cell carcinoma, and basal cell carcinoma), secondary hyperparathyroidism, and autoimmune diseases (systemic lupus erythematosus, type I diabetes, multiple sclerosis, and organ transplantation).
  • Furthermore, encouraging results have been obtained with VDR ligands in clinical trials of prostate cancer and hepatocellular carcinoma.

  • MedlinePlus Health Information. consumer health - Vitamin D.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15798098.001).
  • [ISSN] 0163-769X
  • [Journal-full-title] Endocrine reviews
  • [ISO-abbreviation] Endocr. Rev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ligands; 0 / Receptors, Calcitriol; 1406-16-2 / Vitamin D
  • [Number-of-references] 284
  •  go-up   go-down


8. Wang X, Wang Y, Yu L, Sakakura K, Visus C, Schwab JH, Ferrone CR, Favoino E, Koya Y, Campoli MR, McCarthy JB, DeLeo AB, Ferrone S: CSPG4 in cancer: multiple roles. Curr Mol Med; 2010 Jun;10(4):419-29
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CSPG4 in cancer: multiple roles.
  • Chondroitin sulfate proteoglycan 4 (CSPG4), also known as High Molecular Weight-Melanoma Associated Antigen, is a cell surface proteoglycan which has been recently shown to be expressed not only by melanoma cells, but also by various types of human carcinoma and sarcoma.
  • Furthermore, at least in squamous cell carcinoma of head and neck and in basal breast carcinoma, CSPG4 is expressed by cancer stem cells.
  • CSPG4 plays an important role in tumor cell growth and survival.
  • [MeSH-minor] Aldehyde Dehydrogenase / metabolism. Animals. Antibodies, Monoclonal / therapeutic use. Breast Neoplasms / metabolism. Cell Line, Tumor. Female. Head and Neck Neoplasms / metabolism. Humans. Immunotherapy. In Vitro Techniques. Male. Melanoma / metabolism. Neoplastic Stem Cells / metabolism. T-Lymphocytes / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20455858.001).
  • [ISSN] 1875-5666
  • [Journal-full-title] Current molecular medicine
  • [ISO-abbreviation] Curr. Mol. Med.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01CA105500; United States / NCI NIH HHS / CA / R01CA138188; United States / NCI NIH HHS / CA / R01CA82295; United States / NCI NIH HHS / CA / R03CA141086-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / CSPG4 protein, human; 0 / Chondroitin Sulfate Proteoglycans; 0 / Membrane Proteins; EC 1.2.1.3 / ALDH1A1 protein, human; EC 1.2.1.3 / Aldehyde Dehydrogenase
  • [Number-of-references] 58
  •  go-up   go-down


9. Yang Z, Sui Y, Xiong S, Liour SS, Phillips AC, Ko L: Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation. Nucleic Acids Res; 2007;35(6):1919-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation.
  • We show here that the CoAA gene is embryonically expressed and alternatively spliced in multiple tissues to three splice variants, CoAA, CoAM and CoAR.
  • During retinoic-acid-induced P19 stem cell differentiation, the expression of CoAA undergoes a rapid switch to its dominant negative splice variant CoAM in the cavity of the embryoid body.
  • Using a CoAA minigene cassette, we find that the switched alternative splicing of CoAA and CoAM is regulated by the cis-regulating sequence upstream of the CoAA basal promoter.
  • These results together suggest that the upstream regulatory sequence contributes to alternative splicing of the CoAA gene during stem cell differentiation, and its selective loss in human cancers potentially deregulates CoAA alternative splicing and alters stem cell differentiation.
  • [MeSH-minor] Amino Acid Sequence. Animals. Base Sequence. Carcinoma, Embryonal / genetics. Carcinoma, Embryonal / metabolism. Cell Differentiation. Cell Line, Tumor. DNA-Binding Proteins / biosynthesis. Gene Expression Regulation, Developmental. High Mobility Group Proteins / biosynthesis. Mice. Molecular Sequence Data. Nuclear Matrix-Associated Proteins / metabolism. RNA-Binding Proteins / metabolism. Regulatory Elements, Transcriptional. SOXD Transcription Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2002 Oct 11;298(5592):416-9 [12376702.001]
  • [Cites] RNA. 2002 Sep;8(9):1102-11 [12358429.001]
  • [Cites] EMBO J. 2003 Mar 17;22(6):1359-69 [12628928.001]
  • [Cites] Cardiovasc Res. 2003 May 1;58(2):292-302 [12757864.001]
  • [Cites] J Cell Biol. 1982 Aug;94(2):253-62 [7107698.001]
  • [Cites] Annu Rev Genet. 1989;23:527-77 [2694943.001]
  • [Cites] Nature. 1990 Mar 29;344(6265):435-9 [1690859.001]
  • [Cites] Mol Cell Biol. 1993 Nov;13(11):6742-51 [7692231.001]
  • [Cites] Trends Biochem Sci. 1995 Jun;20(6):235-40 [7543225.001]
  • [Cites] Development. 1999 Feb;126(3):535-46 [9876182.001]
  • [Cites] Cell. 1999 Feb 5;96(3):307-10 [10025395.001]
  • [Cites] Nucleic Acids Res. 1999 Mar 15;27(6):1409-20 [10037800.001]
  • [Cites] Mol Genet Metab. 1999 Jul;67(3):183-93 [10381326.001]
  • [Cites] Curr Opin Cell Biol. 1999 Jun;11(3):363-71 [10395553.001]
  • [Cites] Cell Biol Int. 2004;28(11):791-9 [15563401.001]
  • [Cites] J Cell Sci. 2004 Dec 15;117(Pt 26):6261-3 [15591240.001]
  • [Cites] J Cell Biochem. 2005 Feb 1;94(2):257-65 [15546139.001]
  • [Cites] Trends Mol Med. 2005 Jan;11(1):5-9 [15649816.001]
  • [Cites] Gene. 2005 Jan 3;344:1-20 [15656968.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Apr;42(4):342-57 [15648050.001]
  • [Cites] FEBS J. 2005 May;272(9):2118-31 [15853797.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):262-8 [15901495.001]
  • [Cites] J Biol Chem. 2005 Jun 3;280(22):21022-8 [15793308.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 May;6(5):386-98 [15956978.001]
  • [Cites] Mol Cell Biol. 2005 Jul;25(13):5307-16 [15964789.001]
  • [Cites] Mol Cell Biol. 2005 Aug;25(15):6734-46 [16024807.001]
  • [Cites] Mol Cell Biol. 2005 Aug;25(16):6912-20 [16055705.001]
  • [Cites] Trends Biochem Sci. 2005 Sep;30(9):515-21 [16023350.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14290-5 [16183747.001]
  • [Cites] Glia. 2006 Jan 1;53(1):43-56 [16158417.001]
  • [Cites] RNA. 2006 Jan;12(1):111-21 [16373496.001]
  • [Cites] Cell Cycle. 2006 Feb;5(4):347-51 [16479168.001]
  • [Cites] Nat Cell Biol. 2006 Jul;8(7):756-63 [16767080.001]
  • [Cites] Oncogene. 2007 Feb 8;26(6):822-35 [16878147.001]
  • [Cites] Gene. 1999 Nov 1;239(2):341-9 [10548736.001]
  • [Cites] Cell. 2003 May 30;113(5):551-2 [12787492.001]
  • [Cites] Microbiol Mol Biol Rev. 2003 Sep;67(3):343-59, table of contents [12966139.001]
  • [Cites] J Biol Chem. 2003 Oct 31;278(44):42750-60 [12917399.001]
  • [Cites] Mol Cell Biol. 2004 Jan;24(1):442-53 [14673176.001]
  • [Cites] FEBS Lett. 2004 Feb 27;560(1-3):192-8 [14988021.001]
  • [Cites] EMBO J. 2004 Apr 21;23(8):1834-44 [15057274.001]
  • [Cites] EMBO J. 2004 Apr 21;23(8):1782-91 [15057275.001]
  • [Cites] RNA. 2004 Oct;10(10):1489-98 [15383674.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):6212-7 [10823961.001]
  • [Cites] Mol Cell Biol. 2001 Feb;21(4):1285-96 [11158314.001]
  • [Cites] J Biol Chem. 2001 Sep 7;276(36):33375-83 [11443112.001]
  • [Cites] Nature. 2001 Nov 1;414(6859):92-7 [11689953.001]
  • [Cites] Nat Genet. 2002 Jan;30(1):13-9 [11753382.001]
  • [Cites] Curr Biol. 2002 Jan 8;12(1):1-11 [11790298.001]
  • [Cites] Curr Biol. 2002 Jan 8;12(1):13-25 [11790299.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1146-51 [11818535.001]
  • [Cites] Cell. 2002 Feb 22;108(4):501-12 [11909521.001]
  • [Cites] Nat Rev Genet. 2002 May;3(5):370-9 [11988762.001]
  • [Cites] Curr Opin Genet Dev. 2002 Aug;12(4):441-6 [12100890.001]
  • [Cites] Dev Cell. 2002 Aug;3(2):167-70 [12194848.001]
  • [Cites] FEBS Lett. 2002 Nov 6;531(2):109-14 [12417296.001]
  • (PMID = 17337438.001).
  • [ISSN] 1362-4962
  • [Journal-full-title] Nucleic acids research
  • [ISO-abbreviation] Nucleic Acids Res.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ294957
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CoAA protein, mouse; 0 / DNA-Binding Proteins; 0 / High Mobility Group Proteins; 0 / Nuclear Matrix-Associated Proteins; 0 / Oncogene Proteins; 0 / PTB-associated splicing factor; 0 / RNA-Binding Proteins; 0 / SOXD Transcription Factors; 0 / Sox6 protein, mouse; 0 / Transcription Factors; 0 / p54nrb protein, mouse
  • [Other-IDs] NLM/ PMC1874587
  •  go-up   go-down


10. McCalla-Martin AC, Chen X, Linder KE, Estrada JL, Piedrahita JA: Varying phenotypes in swine versus murine transgenic models constitutively expressing the same human Sonic hedgehog transcriptional activator, K5-HGLI2 Delta N. Transgenic Res; 2010 Oct;19(5):869-87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The keratinocyte-specific human transgene, K5-hGli2 Delta N, was used to produce transgenic porcine lines via somatic cell nuclear transfer techniques.
  • In mice, K5-hGli2 Delta N induces epithelial downgrowths resembling basal cell carcinomas.
  • Our porcine model also developed these basal cell carcinoma-like lesions, however gross tumor development was not appreciated.
  • These findings indicate a need for a multiple species animal model approach in order to better understand the role of Gli2 in mammalian skin.

  • MedlinePlus Health Information. consumer health - Skin Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Rev Cancer. 2002 May;2(5):361-72 [12044012.001]
  • [Cites] J Invest Dermatol. 2009 Mar;129(3):635-40 [18754037.001]
  • [Cites] Nat Genet. 1998 Sep;20(1):54-7 [9731531.001]
  • [Cites] Cell. 1996 Jun 14;85(6):841-51 [8681379.001]
  • [Cites] Oncogene. 1999 Dec 20;18(55):7852-9 [10630638.001]
  • [Cites] Dermatology. 2004;209(2):126-31 [15316166.001]
  • [Cites] Anat Histol Embryol. 1985 Jun;14(2):97-115 [3161419.001]
  • [Cites] Eur J Cancer. 2006 Mar;42(4):437-45 [16406505.001]
  • [Cites] Nucleic Acids Res. 2004 Feb 11;32(3):e25 [14960709.001]
  • [Cites] Clin Exp Rheumatol. 1990 Mar-Apr;8(2):145-50 [1692520.001]
  • [Cites] Development. 1998 Jul;125(14 ):2533-43 [9636069.001]
  • [Cites] Cancer Res. 1997 Jun 15;57(12):2336-40 [9192803.001]
  • [Cites] Nat Med. 2005 Nov;11(11):1197-204 [16244652.001]
  • [Cites] Nature. 1996 Oct 3;383(6599):407-13 [8837770.001]
  • [Cites] Biochem J. 2007 May 1;403(3):369-79 [17419683.001]
  • [Cites] Nature. 2003 Oct 23;425(6960):846-51 [14520411.001]
  • [Cites] Arch Dermatol. 1967 Oct;96(4):357-63 [4862694.001]
  • [Cites] Anim Biotechnol. 2008;19(2):71-9 [18432397.001]
  • [Cites] J Invest Dermatol. 1964 Jul;42:11-21 [14209446.001]
  • [Cites] J Anat. 1986 Feb;144:201-20 [3693045.001]
  • [Cites] Cloning Stem Cells. 2002;4(2):105-12 [12171703.001]
  • [Cites] Science. 2008 Sep 26;321(5897):1837-41 [18818360.001]
  • [Cites] Science. 1996 Jun 14;272(5268):1668-71 [8658145.001]
  • [Cites] Hum Mol Genet. 2005 Aug 1;14(15):2181-8 [15994174.001]
  • [Cites] BMC Genomics. 2006 Dec 28;7:328 [17194308.001]
  • [Cites] Carcinogenesis. 2006 Aug;27(8):1670-5 [16513681.001]
  • [Cites] Wound Repair Regen. 2001 Mar-Apr;9(2):66-76 [11350644.001]
  • [Cites] Cancer Res. 2002 Sep 15;62(18):5308-16 [12235001.001]
  • [Cites] Nat Genet. 1996 Sep;14 (1):78-81 [8782823.001]
  • [Cites] Dermatol Ther. 2004;17 Suppl 1:6-15 [14728694.001]
  • [Cites] Curr Probl Dermatol. 1978;7:39-52 [752456.001]
  • [Cites] Cutis. 2006 Sep;78(3):185-8 [17036662.001]
  • [Cites] Nat Rev Cancer. 2008 Oct;8(10 ):743-54 [18813320.001]
  • [Cites] J Reprod Fertil Suppl. 1993;48:61-73 [8145215.001]
  • [Cites] J Invest Dermatol. 2001 May;116(5):739-42 [11348463.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3438-43 [10725363.001]
  • [Cites] Oncogene. 2002 Aug 15;21(36):5529-39 [12165851.001]
  • [Cites] Am J Med Genet A. 2003 Nov 15;123A(1):5-28 [14556242.001]
  • [Cites] Nature. 1997 Oct 23;389(6653):876-81 [9349822.001]
  • [Cites] Cancer Lett. 2005 Jul 28;225(2):181-92 [15978322.001]
  • [Cites] Histochem Cell Biol. 2008 Jun;129(6):705-33 [18461349.001]
  • [Cites] Mol Cell Biol. 1993 Jun;13(6):3176-90 [7684490.001]
  • [Cites] Genes Dev. 2003 Jan 15;17(2):282-94 [12533516.001]
  • [Cites] J Dermatol Sci. 1998 May;17(1):15-23 [9651824.001]
  • [Cites] J Anat. 1982 Jan;134(Pt 1):139-48 [7076540.001]
  • [Cites] Acta Histochem. 1991;90(1):87-91 [1710864.001]
  • [Cites] Arch Dermatol Res. 1991;283(7):465-71 [1724897.001]
  • [Cites] J Anat. 1990 Jun;170:1-9 [2254156.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10 (7):757-62 [11257109.001]
  • [Cites] Science. 1997 May 2;276(5313):817-21 [9115210.001]
  • [Cites] J Immunol. 2004 Mar 1;172(5):2731-8 [14978070.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2577-85 [15277480.001]
  • [Cites] Br J Dermatol. 2006 Apr;154(4):619-23 [16536802.001]
  • [Cites] Clin Exp Dermatol. 2006 Nov;31(6):807-12 [16981909.001]
  • [Cites] Arch Dermatol Res. 1991;283(7):480-2 [1724898.001]
  • [Cites] Br J Dermatol. 1995 Oct;133(4):501-11 [7577575.001]
  • [Cites] J Investig Dermatol Symp Proc. 2005 Dec;10(3):247-51 [16382675.001]
  • [Cites] Am J Anat. 1986 Jun;176(2):207-19 [3739948.001]
  • [Cites] Science. 1987 Apr 3;236(4797):70-3 [3563490.001]
  • [Cites] Arch Dermatol Res. 1981;270(4):391-401 [7283467.001]
  • [Cites] Nat Genet. 2000 Mar;24(3):216-7 [10700170.001]
  • [Cites] Am J Pathol. 2003 Dec;163(6):2173-8 [14633591.001]
  • [Cites] Eur J Cell Biol. 1992 Oct;59(1):127-37 [1281771.001]
  • [Cites] Vet Pathol. 2008 Jul;45(4):563-75 [18587106.001]
  • [Cites] J Invest Dermatol. 1991 May;96(5):777-85 [2022886.001]
  • (PMID = 20099029.001).
  • [ISSN] 1573-9368
  • [Journal-full-title] Transgenic research
  • [ISO-abbreviation] Transgenic Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / GLI2 protein, human; 0 / Kruppel-Like Transcription Factors; 0 / Nuclear Proteins; 0 / Recombinant Fusion Proteins; 68238-35-7 / Keratins
  •  go-up   go-down


11. Rütten A, Hantschke M, Angulo J, Requena L: Clear-cell dermal duct tumour: another distinctive, previously underrecognized cutaneous adnexal neoplasm. Histopathology; 2007 Dec;51(6):805-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear-cell dermal duct tumour: another distinctive, previously underrecognized cutaneous adnexal neoplasm.
  • AIMS: To describe 13 examples of clear cell dermal duct tumour, a neoplasm previously underrecognized in the literature.
  • METHODS AND RESULTS: Thirteen examples of a neoplasm that we have named clear-cell dermal duct tumour were studied histopathologically and immunohistochemically.
  • Histopathologically, all lesions consisted of mostly dermal neoplasms mainly composed of multiple solid aggregations of clear cells involving the dermis.
  • In contrast to some other clear cell neoplasms of the skin, which may be associated with diabetes mellitus, none of our cases of clear cell dermal duct tumour developed in a diabetic patient.
  • CONCLUSIONS: We consider these neoplasms to be clear cell dermal duct tumours for the following reasons: (i) the neoplasms were mostly composed of multiple solid aggregations of epithelial clear cells;.
  • [MeSH-minor] Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Bowen's Disease / pathology. Carcinoma, Basal Cell / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged. Nevus / pathology. Skin Diseases / pathology


12. Thompson MS, Johansson A, Johansson T, Andersson-Engels S, Svanberg S, Bendsoe N, Svanberg K: Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. Appl Opt; 2005 Jul 1;44(19):4023-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A system for interstitial photodynamic therapy with delta-aminolaevulinic acid and multiple optical fibers has been developed.
  • Data from the first clinical treatments on nodular basal cell carcinomas indicate a major treatment-induced light absorption increase, rapid sensitizer photobleaching, and a relatively constant global tissue oxygen saturation level during the treatment.
  • [MeSH-major] Aminolevulinic Acid / administration & dosage. Carcinoma, Basal Cell / drug therapy. Fiber Optic Technology / instrumentation. Photochemotherapy / instrumentation. Skin Neoplasms / drug therapy. Spectrometry, Fluorescence / instrumentation. Therapy, Computer-Assisted / instrumentation. User-Computer Interface

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16004049.001).
  • [ISSN] 0003-6935
  • [Journal-full-title] Applied optics
  • [ISO-abbreviation] Appl Opt
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 88755TAZ87 / Aminolevulinic Acid
  •  go-up   go-down


13. Sun S, Rao NL, Venable J, Thurmond R, Karlsson L: TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets; 2007 Dec;6(4):223-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The TLR7 agonist imiquimod is currently used as a topical treatment for genital warts caused by human papillomavirus (HPV), actinic keratosis (AK) and superficial basal cell carcinoma.
  • Pre-clinical animal models as well as genetic linkage studies have indicated that TLR7/9 play a pivotal role in the aforementioned as well as other IMID such as multiple sclerosis (MS), inflammatory bowl disease (IBD)/colitis and psoriasis.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18220957.001).
  • [ISSN] 1871-5281
  • [Journal-full-title] Inflammation & allergy drug targets
  • [ISO-abbreviation] Inflamm Allergy Drug Targets
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United Arab Emirates
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Toll-Like Receptor 7; 0 / Toll-Like Receptor 9
  • [Number-of-references] 174
  •  go-up   go-down


14. Lane JE, Goodrich RG, Kent DE, Milde P: Use of Mohs micrographic surgery to treat basal cell carcinoma arising in a nevus sebaceous in an African American patient. J Cutan Med Surg; 2007 Jul-Aug;11(4):158-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of Mohs micrographic surgery to treat basal cell carcinoma arising in a nevus sebaceous in an African American patient.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Head and Neck Neoplasms / surgery. Neoplasms, Multiple Primary / surgery. Nevus / surgery. Scalp. Skin Neoplasms / surgery


15. Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R: P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res; 2007 May 15;67(10):4915-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
  • In several neoplastic diseases, including hepatocellular carcinoma, the expression of P-glycoprotein and cyclooxygenase-2 (COX-2) are often increased and involved in drug resistance and poor prognosis.
  • Because COX-2 induces P-glycoprotein expression, we evaluated the effect of celecoxib, a specific inhibitor of COX-2 activity, on P-glycoprotein-mediated resistance to apoptosis in cell lines expressing multidrug resistant (MDR) phenotype.
  • Experiments were done using MDR-positive and parental cell lines at basal conditions and after exposure to 10 or 50 micromol/L celecoxib.
  • We found that 10 micromol/L celecoxib reduced P-glycoprotein, Bcl-x(L), and Bcl-2 expression, and induced translocation of Bax from cytosol to mitochondria and cytochrome c release into cytosol in MDR-positive hepatocellular carcinoma cells.
  • No effect was shown on parental drug-sensitive or on MDR-positive hepatocellular carcinoma cells after transfection with MDR1 small interfering RNA.
  • In conclusion, these results show that relatively low concentrations of celecoxib induce cell apoptosis in MDR cell lines.
  • [MeSH-major] Apoptosis / drug effects. Carcinoma, Hepatocellular / drug therapy. Liver Neoplasms / drug therapy. P-Glycoprotein / metabolism. Pyrazoles / pharmacology. Sulfonamides / pharmacology
  • [MeSH-minor] Animals. Celecoxib. Cell Line, Tumor. Cyclooxygenase 2 / biosynthesis. Cytochromes c / metabolism. Cytochromes c / secretion. Drug Resistance, Multiple. HT29 Cells. Humans. Mice. Mitochondria / metabolism. Mitochondria / secretion. NIH 3T3 Cells. Proto-Oncogene Proteins c-bcl-2 / biosynthesis. bcl-2-Associated X Protein / metabolism. bcl-X Protein / biosynthesis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • Hazardous Substances Data Bank. CELECOXIB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17510421.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / P-Glycoprotein; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Pyrazoles; 0 / Sulfonamides; 0 / bcl-2-Associated X Protein; 0 / bcl-X Protein; 9007-43-6 / Cytochromes c; EC 1.14.99.1 / Cyclooxygenase 2; JCX84Q7J1L / Celecoxib
  •  go-up   go-down


16. Jiang Z, Li C, Fischer A, Dresser K, Woda BA: Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol; 2005 Feb;123(2):231-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
  • When carcinoma was present, red cytoplasmic granular staining (AMACR) in the malignant glands and cells and dark brown nuclear (p63) and cytoplasmic (34betaE12) staining in basal cells of adjacent nonmalignant glands were found.
  • Of 82 cases of small foci of prostatic adenocarcinoma, 78 (95%) expressed AMACR; all malignant glands were negative for basal cell staining.
  • All benign glands adjacent to malignant glands were recognized easily by basal cell marker positivity and little or no AMACR expression.
  • No benign glands were simultaneously positive for AMACR and negative for basal cell markers (specificity, 100%).
  • Our results indicate that immunohistochemistry with a 3-antibody cocktail and double chromogen is a simple and easy assay that can be used as a routine test, which overcomes the problems of studying small lesions in prostate needle biopsies with multiple immunohistochemical stains.

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15842047.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 5.1.- / Racemases and Epimerases; EC 5.1.99.4 / alpha-methylacyl-CoA racemase
  •  go-up   go-down


17. Chang MY, Chen YM, Chen YC, Tian YC, Fang JT, Yang CW: Concurrent renal cell carcinoma and central nervous system lymphoma in a patient with autosomal dominant polycystic kidney disease. Med Princ Pract; 2009;18(6):486-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concurrent renal cell carcinoma and central nervous system lymphoma in a patient with autosomal dominant polycystic kidney disease.
  • OBJECTIVE: To report an unusual case of synchronous renal cell carcinoma and CNS lymphoma in a patient with autosomal dominant polycystic kidney disease (ADPKD).
  • A brain CT scan revealed multiple enhanced lesions in the basal ganglia and the right occipital lobe.
  • A needle biopsy of the renal mass revealed renal cell carcinoma and unilateral nephrectomy was performed successfully.
  • This report highlights the need for clinicians to remain alert to the possibility of double malignancies while caring for ADPKD patients, especially when multiple unexplained manifestations exist.
  • [MeSH-major] Carcinoma, Renal Cell / complications. Central Nervous System Neoplasms / complications. Kidney Neoplasms / complications. Lymphoma / complications. Neoplasms, Second Primary. Polycystic Kidney, Autosomal Dominant / complications


18. Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, Feldman MD, Brose MS: Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther; 2009 May;8(10):907-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC).
  • To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs).
  • We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH).
  • [MeSH-minor] Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Case-Control Studies. Chromosome Deletion. Comparative Genomic Hybridization. DNA, Neoplasm / analysis. Female. Gene Dosage. Gene Expression. Humans. Loss of Heterozygosity. Mouth Neoplasms / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism


19. Sasaki R, Saito K, Watanabe Y, Takayama Y, Fujii K, Agawa K, Miyashita T, Ando T, Akizuki T: Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations. J Hum Genet; 2009 Jul;54(7):398-402
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations.
  • Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder characterized by developmental abnormalities and a predisposition to cancers.
  • Two unrelated patients, 21- and 16-year-old males, with cleft lip and palate and multiple jaw cysts, were diagnosed according to clinical criteria.
  • [MeSH-major] Basal Cell Nevus Syndrome / complications. Basal Cell Nevus Syndrome / genetics. Cleft Lip / complications. Cleft Palate / complications. Genetic Predisposition to Disease. Mutation / genetics. Receptors, Cell Surface / genetics


20. Demirtaşoglu M, Ilknur T, Lebe B, Kuşku E, Akarsu S, Ozkan S: Evaluation of dermoscopic and histopathologic features and their correlations in pigmented basal cell carcinomas. J Eur Acad Dermatol Venereol; 2006 Sep;20(8):916-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of dermoscopic and histopathologic features and their correlations in pigmented basal cell carcinomas.
  • BACKGROUND: Because of their clinical similarities, pigmented basal cell carcinomas (BCCs) can be confused with melanocytic pigmented lesions especially with melanoma.
  • RESULTS: In addition to ulceration, large grey-blue ovoid nests, multiple grey-blue globules, maple leaf areas and arborizing telangiectasia; dermoscopically yellow-brown, whitish-yellow, and black-dark brown colour showed statistically significant correlation with their histopathologic counterparts (P < 0.05).
  • CONCLUSIONS: Ulceration, large grey-blue ovoid nests, multiple grey-blue globules, maple leaf-like areas and arborizing telangiectasia, which are specific dermoscopic features for the diagnosis of pigmented BCC, were found to correlate with their histopathologic counterparts.
  • In conclusion, dermoscopy can be described as a valuable tool for the diagnosis of pigmented basal cell carcinomas.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16922937.001).
  • [ISSN] 0926-9959
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


21. Chen YR, Fu YN, Lin CH, Yang ST, Hu SF, Chen YT, Tsai SF, Huang SF: Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene; 2006 Feb 23;25(8):1205-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutations in the kinase domain of epidermal growth factor receptor (EGFR) are associated with clinical responsiveness to gefitinib in patients with non-small-cell lung cancers (NSCLC).
  • All tested EGFR mutants have high basal phosphorylation at multiple tyrosine residues.
  • [MeSH-minor] Animals. COS Cells. Carcinoma, Non-Small-Cell Lung / drug therapy. Carcinoma, Non-Small-Cell Lung / metabolism. Carcinoma, Non-Small-Cell Lung / pathology. Cercopithecus aethiops. Epidermal Growth Factor / pharmacology. Immunoprecipitation. Lung Neoplasms / drug therapy. Lung Neoplasms / metabolism. Lung Neoplasms / pathology. Phosphorylation / drug effects. Tumor Cells, Cultured. Tyrosine / metabolism. Ubiquitin / metabolism

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. L-TYROSINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Oncogene (2006) 25, 1205-1215. doi:10.1038/sj.onc.1209159; published online 3 October 2005.
  • (PMID = 16205628.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Quinazolines; 0 / Ubiquitin; 42HK56048U / Tyrosine; 62229-50-9 / Epidermal Growth Factor; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; S65743JHBS / gefitinib
  •  go-up   go-down


22. Surendran K, Selassie M, Liapis H, Krigman H, Kopan R: Reduced Notch signaling leads to renal cysts and papillary microadenomas. J Am Soc Nephrol; 2010 May;21(5):819-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Conditional inactivation of the DNA binding factor RBP-J, which mediates Notch signaling, also resulted in multiple congenital cysts arising from the proximal tubule.
  • Moreover, a few stratified foci/microadenomas containing hyperproliferative cells, resembling precursors of papillary renal cell carcinoma, formed in these proximal tubules.
  • Epithelial stratification correlated neither with reduced expression of the transcriptional regulator of ciliary proteins TCF2/HNF1beta nor with loss of apical-basal polarity.
  • Furthermore, post hoc analysis of human class 1 papillary renal cell carcinoma revealed reduced Notch activity in these tumors, resulting from abundant expression of a potent inhibitor of canonical Notch signaling, KyoT3/FHL1B.
  • In summary, these data suggest that canonical Notch signaling maintains the alignment of cell division in the proximal tubules during nephrogenesis and that perturbations in Notch signaling may lead to cystic renal disease and tumorigenesis.

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cysts.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2007 Feb;38(2):239-46 [17056094.001]
  • [Cites] Annu Rev Cell Dev Biol. 2006;22:509-29 [16822174.001]
  • [Cites] EMBO J. 2007 Mar 21;26(6):1487-98 [17318179.001]
  • [Cites] J Am Soc Nephrol. 2007 Jun;18(6):1855-71 [17513324.001]
  • [Cites] Development. 2007 Jul;134(13):2533-9 [17537789.001]
  • [Cites] J Am Soc Nephrol. 2007 Jul;18(7):2014-20 [17568016.001]
  • [Cites] BMC Nephrol. 2007;8:12 [17714589.001]
  • [Cites] Neurodegener Dis. 2008;5(3-4):160-2 [18322378.001]
  • [Cites] Nat Med. 2008 Mar;14(3):290-8 [18311147.001]
  • [Cites] Hum Mol Genet. 2008 Jun 1;17(11):1578-90 [18263895.001]
  • [Cites] Kidney Int. 2008 Jun;73(11):1240-50 [18418349.001]
  • [Cites] J Am Soc Nephrol. 2008 Jun;19(6):1139-57 [18337488.001]
  • [Cites] Nat Genet. 2008 Aug;40(8):1010-5 [18604206.001]
  • [Cites] Biochim Biophys Acta. 2008 Dec;1779(12):805-10 [18760388.001]
  • [Cites] Curr Top Dev Biol. 2008;84:249-310 [19186246.001]
  • [Cites] J Clin Invest. 2009 Feb;119(2):349-61 [19139564.001]
  • [Cites] J Clin Invest. 2009 Mar;119(3):428-37 [19252258.001]
  • [Cites] Cell. 2009 Apr 17;137(2):216-33 [19379690.001]
  • [Cites] Pathology. 2009;41(4):335-41 [19404845.001]
  • [Cites] Hum Mol Genet. 2009 Jun 15;18(12):2166-76 [19321600.001]
  • [Cites] Nature. 2000 Jun 22;405(6789):966-70 [10879540.001]
  • [Cites] Development. 2001 Feb;128(4):491-502 [11171333.001]
  • [Cites] EMBO J. 2001 Jul 2;20(13):3427-36 [11432830.001]
  • [Cites] J Am Soc Nephrol. 2002 Apr;13(4):875-86 [11912246.001]
  • [Cites] Nat Immunol. 2002 May;3(5):443-50 [11967543.001]
  • [Cites] Nat Genet. 2009 Jul;41(7):793-9 [19543268.001]
  • [Cites] Dev Biol. 2009 Sep 15;333(2):312-23 [19591821.001]
  • [Cites] J Clin Invest. 2009 Nov;119(11):3290-300 [19855135.001]
  • [Cites] Nat Med. 2010 Jan;16(1):106-10 [19966811.001]
  • [Cites] Dev Biol. 2010 Jan 15;337(2):386-95 [19914235.001]
  • [Cites] J Am Soc Nephrol. 2010 Feb;21(2):295-302 [19959710.001]
  • [Cites] Cell. 2002 Apr 19;109(2):157-68 [12007403.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Dec 13;299(4):569-73 [12459176.001]
  • [Cites] Nat Genet. 2003 Feb;33(2):129-37 [12514735.001]
  • [Cites] Genes Dev. 2003 May 15;17(10):1213-8 [12730123.001]
  • [Cites] Genes Dev. 2003 May 15;17(10):1207-12 [12730124.001]
  • [Cites] Transgenic Res. 2003 Aug;12(4):521-2 [12885173.001]
  • [Cites] Development. 2003 Oct;130(20):5019-29 [12930775.001]
  • [Cites] Development. 2003 Oct;130(20):5031-42 [12952904.001]
  • [Cites] Nature. 2004 Jan 8;427(6970):121-8 [14712268.001]
  • [Cites] EMBO J. 2004 Apr 7;23(7):1657-68 [15029248.001]
  • [Cites] Dev Biol. 2004 May 1;269(1):81-94 [15081359.001]
  • [Cites] Development. 2004 Aug;131(16):4085-93 [15269167.001]
  • [Cites] J Cell Biol. 1994 Sep;126(6):1509-26 [8089182.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8984-8 [7522327.001]
  • [Cites] Mol Cell Biol. 1998 Jan;18(1):644-54 [9418910.001]
  • [Cites] Dev Cell. 2005 May;8(5):677-88 [15866159.001]
  • [Cites] Development. 2005 Jun;132(12):2809-23 [15930111.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5628-37 [15994935.001]
  • [Cites] Nature. 2005 Sep 8;437(7056):275-80 [16094321.001]
  • [Cites] Nat Genet. 2006 Jan;38(1):21-3 [16341222.001]
  • [Cites] Am J Hum Genet. 2006 Jul;79(1):169-73 [16773578.001]
  • [Cites] Kidney Int. 2006 Sep;70(5):854-64 [16816842.001]
  • [Cites] Development. 2007 Feb;134(4):801-11 [17229764.001]
  • (PMID = 20378824.001).
  • [ISSN] 1533-3450
  • [Journal-full-title] Journal of the American Society of Nephrology : JASN
  • [ISO-abbreviation] J. Am. Soc. Nephrol.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK066408; United States / NIDDK NIH HHS / DK / 5P30DK07933; United States / NIDDK NIH HHS / DK / DK066408
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Cell Cycle Proteins; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / FHL1 protein, human; 0 / HEY1 protein, human; 0 / Hnf1b protein, mouse; 0 / Intracellular Signaling Peptides and Proteins; 0 / LIM Domain Proteins; 0 / Muscle Proteins; 0 / Receptors, Notch; 138674-15-4 / Hepatocyte Nuclear Factor 1-beta
  • [Other-IDs] NLM/ PMC2865744
  •  go-up   go-down


23. Uphoff J, Woziwodzki J, Schattka SO, Kollias A: [Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis]. Aktuelle Urol; 2008 Sep;39(5):373-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Changes in the morphology of the prostate carcinoma are specially known for the occurrence of small-cell neuroendocrine and undifferentiated carcinomas.
  • [MeSH-major] Adenocarcinoma / secondary. Androgen Antagonists / therapeutic use. Antineoplastic Agents, Hormonal / therapeutic use. Carcinoma, Basal Cell / secondary. Carcinoma, Transitional Cell / secondary. Cell Transformation, Neoplastic / pathology. Diphosphonates / therapeutic use. Gonadotropin-Releasing Hormone / antagonists & inhibitors. Neoplasms, Multiple Primary / drug therapy. Penile Neoplasms / secondary. Prostatic Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18798127.001).
  • [ISSN] 0001-7868
  • [Journal-full-title] Aktuelle Urologie
  • [ISO-abbreviation] Aktuelle Urol
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Androgen Antagonists; 0 / Antineoplastic Agents, Hormonal; 0 / Biomarkers, Tumor; 0 / Diphosphonates; 33515-09-2 / Gonadotropin-Releasing Hormone
  •  go-up   go-down


24. Argenziano G, Zalaudek I, Ferrara G, Johr R, Langford D, Puig S, Soyer HP, Malvehy J: Dermoscopy features of melanoma incognito: indications for biopsy. J Am Acad Dermatol; 2007 Mar;56(3):508-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 6) In patients with multiple nevi, biopsy lesions changing after short-term follow-up.
  • [MeSH-minor] Adolescent. Adult. Biopsy. Carcinoma, Basal Cell / pathology. Diagnosis, Differential. Female. Humans. Middle Aged. Nevus / pathology. Nevus, Pigmented / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Am Acad Dermatol. 2010 May;62(5):893-4 [20398822.001]
  • [CommentIn] J Am Acad Dermatol. 2008 Sep;59(3):533 [18694689.001]
  • (PMID = 17113189.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S: Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant; 2008 Nov;8(11):2192-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Skin cancers are the most frequent malignancies in organ transplant recipients (OTR), with 95% being nonmelanoma skin cancers (NMSC), especially squamous (SCC) and basal cell carcinomas.
  • Most OTR with a first SCC subsequently develop multiple NMSC within 5 years, highlighting the concept of 'field cancerization', and are also at high risk for noncutaneous cancers.
  • Although the threshold of skin cancer necessitating revision of immunosuppression is debated, this measure should be envisaged at the occurrence of the first SCC, or in case of multiple non-SCC NMSC.
  • [MeSH-minor] Carcinoma, Basal Cell / etiology. Carcinoma, Squamous Cell / etiology. Clinical Trials as Topic. Humans. Immunosuppressive Agents / adverse effects. Incidence. Keratosis / therapy. Medical Oncology / methods. Risk. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Organ Transplantation.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18782290.001).
  • [ISSN] 1600-6143
  • [Journal-full-title] American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • [ISO-abbreviation] Am. J. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Immunosuppressive Agents
  • [Number-of-references] 34
  •  go-up   go-down


26. Diaz LK, Cristofanilli M, Zhou X, Welch KL, Smith TL, Yang Y, Sneige N, Sahin AA, Gilcrease MZ: Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod Pathol; 2005 Sep;18(9):1165-75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In vitro data support a role for the alpha6beta4 integrin in tumor cell migration and invasion, particularly in breast carcinoma cells, but clinical data on this potentially important integrin are limited.
  • The beta4 integrin subunit has been shown to cluster with genes characteristic of basal/myoepithelial cells in cDNA microarray analyses of breast cancer, and the subset of breast cancers with increased expression of genes characteristic of basal/myoepithelial cells appears to be particularly aggressive.
  • We evaluated tumor expression of the beta4 integrin subunit gene in a cohort of patients with early invasive breast carcinoma by in situ hybridization and correlated expression levels with multiple clinicopathologic characteristics.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Adhesion Molecules / metabolism. Female. Humans. Immunohistochemistry. In Situ Hybridization. Middle Aged. Prognosis. Protein Subunits / biosynthesis. Protein Subunits / genetics. RNA, Messenger / analysis. Retrospective Studies. Survival Analysis


27. Karsidag S, Ozcan A, Ozkaya O, Ugurlu K, Bas L: Use of wide bipedicled pericranial flap in anterior scalp reconstruction. J Craniofac Surg; 2009 Nov;20(6):2248-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The multiple blood supply of the pericranial tissue enables this versatility, with a rich, anastomosing arterial supply from the supraorbital, supratrochlear, superficial temporal, posterior auricular, and occipital vessels.
  • [MeSH-minor] Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / surgery. Ear, External / blood supply. Fascia / transplantation. Humans. Male. Middle Aged. Periosteum / transplantation. Skin Transplantation


28. Levy J, Cagnano E, Benharroch D, Monos T, Lifshitz T: Collision sebaceous and basal cell carcinomas of the eyelid. Ann Diagn Pathol; 2006 Jun;10(3):157-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision sebaceous and basal cell carcinomas of the eyelid.
  • OBJECTIVE: To report a rare case of collision sebaceous and basal cell carcinomas of the eyelid.
  • Histopathology showed mixed sebaceous as well as basal cell carcinoma with uninvolved surgical margins.
  • CONCLUSION: Sebaceous and basal cell carcinomas can coexist in the eyelid within the same clinical lesion.
  • Because of the potential risk of metastasis of sebaceous carcinoma, close follow-up of the patients is advisable.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Carcinoma, Basal Cell / pathology. Eyelid Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16730311.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


29. Maury G, Girard C, Michot C, Guillot B, Dereure O: [Multiple Bowen disease of the lower limbs in elderly women: a rare clinical subset involving therapeutic difficulties]. Ann Dermatol Venereol; 2009 Jun-Jul;136(6-7):508-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple Bowen disease of the lower limbs in elderly women: a rare clinical subset involving therapeutic difficulties].
  • BACKGROUND: Cutaneous Bowen's disease (CBD) is a form of intraepithelial squamous cell carcinoma that usually presents as a solitary lesion.
  • We report four similar cases of a peculiar and well-delimited clinical subset of multiple Bowen's disease seen in the lower limbs in elderly women and associated with specific therapeutic problems.
  • OBSERVATIONS: Four women aged over 70 years presented with multiple CBD limited to the lower limbs associated with squamous cell and superficial basal cell carcinomas along with actinic keratosis.
  • DISCUSSION: These four cases share numerous clinical similarities: elderly women, markers of chronic sun exposure, lack of other aetiological factors such as arsenic or irradiation, localization of the lesions (multiple and/or continuous layer pattern, restricted to the lower limbs in all cases) and a chronic course.
  • However, while this treatment could be considered a first-line option in multiple CBD, its therapeutic value requires more detailed evaluation.
  • [MeSH-minor] Aged. Aged, 80 and over. Carcinoma, Basal Cell / complications. Female. Humans. Keratosis, Actinic / complications. Photochemotherapy. Sunlight / adverse effects

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19560611.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


30. Papa G, Grandi G, Pascone M: Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma. Pathol Res Pract; 2006;202(9):691-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma.
  • We report a case of melanoma in a basal cell carcinoma collision tumor.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Melanoma / pathology. Neoplasms, Multiple Primary / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Antigens, Neoplasm. Carcinoma, Squamous Cell / pathology. Cheek / pathology. Female. Humans. Immunohistochemistry. Melanoma-Specific Antigens. Neoplasm Proteins / metabolism. S100 Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16876964.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins
  •  go-up   go-down


31. Stern RS: Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol; 2010 Mar;146(3):279-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To estimate the 2007 person prevalence of common types of nonmelanoma skin cancer (NMSC), basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), or both, in the United States using an incidence-based mathematical model; and to compare the prevalence of skin cancer with that of other common cancers.
  • About 1 in 5 seventy-year-olds have had NMSCs, and most of those affected have had multiple NMSCs.
  • [MeSH-minor] Adult. Aged. Carcinoma, Basal Cell / epidemiology. Carcinoma, Basal Cell / pathology. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / pathology. Female. Humans. Incidence. Male. Middle Aged. Prognosis. Retrospective Studies. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20231498.001).
  • [ISSN] 1538-3652
  • [Journal-full-title] Archives of dermatology
  • [ISO-abbreviation] Arch Dermatol
  • [Language] eng
  • [Grant] United States / NIAMS NIH HHS / AR / N01-AR-02446
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


32. Kocabaş E, Ermertcan AT, Bilaç C, Bilaç DB, Temiz P: Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream. Cutan Ocul Toxicol; 2010 Dec;29(4):300-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
  • This report describes the case of a 60-year-old man with nonsyndromic multiple basal cell carcinomas that responded to imiquimod 5% cream.
  • The patient had no additional anomalies suggesting any syndromes associated with multiple basal cell carcinomas.
  • We suggest that patients with multiple basal cell carcinomas should be interviewed about and tested for the associated syndromes, and topical imiquimod should be kept in mind as an alternative therapy choice in these patients.
  • [MeSH-major] Aminoquinolines / therapeutic use. Antineoplastic Agents / therapeutic use. Carcinoma, Basal Cell / drug therapy. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20684662.001).
  • [ISSN] 1556-9535
  • [Journal-full-title] Cutaneous and ocular toxicology
  • [ISO-abbreviation] Cutan Ocul Toxicol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aminoquinolines; 0 / Antineoplastic Agents; 99011-02-6 / imiquimod
  •  go-up   go-down


33. Ramachandran S, Rajaratnam R, Smith AG, Lear JT, Strange RC: Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. J Am Acad Dermatol; 2009 Aug;61(2):247-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
  • BACKGROUND: The rate of development of further basal cell carcinoma (BCC) after first presentation is highly variable.
  • OBJECTIVE: We assessed the risks of developing a subsequent BCC in patients who developed a BCC and a squamous cell carcinoma (SCC) and compared them with patients who developed a BCC only.
  • [MeSH-major] Carcinoma, Basal Cell / epidemiology. Carcinoma, Squamous Cell / epidemiology. Neoplasm Recurrence, Local / epidemiology. Neoplasms, Multiple Primary / epidemiology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19481292.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


34. Falsarella PM, Alves-Filho G, Mazzali M: Skin malignancies in renal transplant recipients: a Brazilian center registry. Transplant Proc; 2008 Apr;40(3):767-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most frequent skin cancer was squamous cell carcinoma (46.2%), in single or multiple lesions (50% each group).
  • Basal cell carcinoma was diagnosed in seven patients; most presented as a single lesion (71.3%).
  • Eight patients presented with more than one histologic type of skin cancer; most frequently squamous and basal cell carcinomas.
  • Kaposi sarcoma was diagnosed in four patients, one of whom also had a basal cell carcinoma.
  • The most frequent tumor was squamous cell carcinoma, isolated or in association with basal cell carcinoma.

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18455011.001).
  • [ISSN] 0041-1345
  • [Journal-full-title] Transplantation proceedings
  • [ISO-abbreviation] Transplant. Proc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Fisher GH, Bangash SJ, Mones J, Geronemus RG: Rapid growth of basal cell carcinoma in a multigestational pregnancy. Dermatol Surg; 2006 Nov;32(11):1418-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid growth of basal cell carcinoma in a multigestational pregnancy.
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Pregnancy Complications, Neoplastic / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Mohs Surgery. Neoplasm Invasiveness. Nose / pathology. Nose / surgery. Pregnancy. Pregnancy, Multiple. Surgical Flaps. Twins


36. Belisle A, Gautier MS, Ghozali F, Plantier F, Wechsler J: A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma. Am J Dermatopathol; 2005 Aug;27(4):319-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
  • Basal cell carcinomas (BCC) are known to co-exist with other cutaneous lesions, but the collision of BCC with malignant melanoma is rare.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Hutchinson's Melanotic Freckle / pathology. Neoplasms, Multiple Primary / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Lentigo maligna melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16121053.001).
  • [ISSN] 0193-1091
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Heitzer E, Lassacher A, Quehenberger F, Kerl H, Wolf P: UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol; 2007 Dec;127(12):2872-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype.
  • Basal cell carcinoma (BCC) shows a wide interpatient variation in lesion accrual.
  • To determine whether certain tumorigenic fingerprints and potentially predisposing patched (PTCH) tumor suppressor single-nucleotide polymorphisms (SNPs) are distributed differently among sporadic BCC patients, we compared the PTCH mutation spectra in early-onset BCC (first lesion at age < 35 years), regular BCC (first lesion at age > or = 35 years and < 10 lesions), and multiple BCC (> or = 10 lesions).
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Carcinoma, Basal Cell / metabolism. DNA Mutational Analysis. Gene Expression Regulation, Neoplastic. Mutation. Receptors, Cell Surface / genetics. Skin Neoplasms / genetics. Skin Neoplasms / metabolism. Ultraviolet Rays

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17597822.001).
  • [ISSN] 1523-1747
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Cell Surface; 0 / patched receptors
  •  go-up   go-down


38. Marty CL, Randle HW, Walsh JS: Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatol Surg; 2005 Jul;31(7 Pt 1):780-2; discussion 782-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A 79-year-old woman being treated with imiquimod 5 days per week for a nodular basal cell developed a verrucous plaque over the treatment area after 7 weeks of therapy.
  • RESULTS: Scouting biopsies demonstrated multiple comedones and ruptured epidermoid cysts.
  • There was no evidence of residual basal cell carcinoma.
  • We report its successful use in the treatment of a nodular basal cell carcinoma.
  • The multiple comedones and ruptured epidermoid cysts are newly reported adverse effects of imiquimod therapy.
  • [MeSH-major] Aminoquinolines / adverse effects. Antineoplastic Agents / adverse effects. Carcinoma, Basal Cell / drug therapy. Skin Diseases / etiology. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16029707.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aminoquinolines; 0 / Antineoplastic Agents; 0 / Dermatologic Agents; 0 / Retinoids; 99011-02-6 / imiquimod
  •  go-up   go-down


39. Fisher GH, Mones J, Gill M, Celebi JT, Geronemus RG: Mohs surgical extirpation of a basal cell carcinoma in a patient with familial multiple trichoepitheliomas. Dermatol Surg; 2005 Nov;31(11 Pt 1):1458-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mohs surgical extirpation of a basal cell carcinoma in a patient with familial multiple trichoepitheliomas.
  • In most cases of basal cell carcinoma and nonmelanoma skin cancer, this is a relatively straightforward process.
  • OBJECTIVE: Our objective is to highlight the histopathologic features that we used to differentiate our patient's near-confluent background of trichoepitheliomas from the basal cell carcinoma that we were extirpating.
  • RESULTS: A 41-year-old white female with a history of familial multiple facial trichoepitheliomas presented for removal of a basal cell carcinoma on her right lower cutaneous lip.
  • The characteristic features of basal cell carcinoma and trichoepithelioma were used to differentiate the basal cell carcinoma that we were removing from the surrounding trichoepitheliomatous neoplasia.
  • CONCLUSION: Mohs surgical extirpation of a basal cell carcinoma in a patient with multiple familial trichoepitheliomas requires a clear understanding of the histopathologic features that differentiate a trichoepithelioma from a basal cell carcinoma.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Carcinoma, Basal Cell / surgery. Facial Neoplasms / genetics. Facial Neoplasms / surgery. Mohs Surgery. Skin Neoplasms / genetics. Skin Neoplasms / surgery

  • Genetic Alliance. consumer health - Basal Cell Carcinoma, Multiple.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16416621.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


40. Ali F, Brown A, Gottwald L, Thomas J: Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature. J Cutan Pathol; 2005 Jul;32(6):445-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
  • The presence of shadow cells within tumor islands composed of follicular germinative cells of an otherwise classic basal cell carcinoma (BCC) has been considered as a distinct diagnostic category of BCC with matrical differentiation.
  • RESULTS: The H&E-stained sections of the hand lesion revealed multiple nodular masses of basaloid follicular germinative cells.
  • [MeSH-major] Carcinoma, Basal Cell / immunology. Carcinoma, Basal Cell / pathology. Heart Transplantation. Immunocompromised Host. Skin Neoplasms / immunology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15953381.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


41. Cheretis C, Angelidou E, Dietrich F, Politi E, Kiaris H, Koutselini H: Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma. Med Sci Monit; 2008 May;14(5):MT13-19
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
  • BACKGROUND: Nuclear morphometry may provide useful diagnostic and prognostic information about basal cell carcinomas (BCCs) of the skin.
  • RESULTS: Increased patient age, multiple localization of BCCs at the time of diagnosis, and a low degree of peripheral palisading at the histological sections of BCCs were associated with BCC recurrence and consequently worse disease-free survival (DFS).
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / pathology. Diagnosis, Computer-Assisted / methods. Skin Neoplasms / diagnosis. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Algorithms. Cell Nucleus / metabolism. Female. Humans. Image Processing, Computer-Assisted. Male. Models, Statistical. Prognosis. Recurrence. Software. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18443558.001).
  • [ISSN] 1234-1010
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  •  go-up   go-down


42. Hengge UR: [Topical therapy of squamous cell carcinoma]. Hautarzt; 2007 May;58(5):412-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Topical therapy of squamous cell carcinoma].
  • Topical treatment is particularly attractive for field cancerization involving multiple non-melanoma skin cancers.
  • [MeSH-major] Carcinoma, Basal Cell / therapy. Carcinoma, Squamous Cell / therapy. Neoplasms, Radiation-Induced / therapy. Skin Neoplasms / therapy. Ultraviolet Rays / adverse effects

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Dermatol. 1995 Feb;131(2):176-81 [7857114.001]
  • [Cites] Mol Immunol. 2003 Jul;39(17-18):1133-6 [12835091.001]
  • [Cites] Arch Dermatol. 2004 Jan;140(1):116-20 [14732670.001]
  • [Cites] J Dermatolog Treat. 2001 Dec;12(4):199-203 [12241628.001]
  • [Cites] Int J Dermatol. 2001 Nov;40(11):709-13 [11737438.001]
  • [Cites] Br J Dermatol. 2005 Oct;153(4):808-10 [16181465.001]
  • [Cites] J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):236-8 [9039175.001]
  • [Cites] J Am Acad Dermatol. 2004 May;50(5):722-33 [15097956.001]
  • [Cites] Arch Dermatol. 2006 Jun;142(6):729-35 [16785375.001]
  • [Cites] Cutis. 2002 Aug;70(2 Suppl):22-9 [12353677.001]
  • [Cites] Br J Dermatol. 2002 Apr;146(4):552-67 [11966684.001]
  • [Cites] J Am Acad Dermatol. 2002 Aug;47(2):258-62 [12140473.001]
  • [Cites] Genitourin Med. 1987 Dec;63(6):390-2 [3323028.001]
  • [Cites] Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003412 [17253489.001]
  • [Cites] J Am Acad Dermatol. 2003 Feb;48(2):227-32 [12582393.001]
  • [Cites] Arch Dermatol. 2001 Jun;137(6):709-11 [11405756.001]
  • [Cites] Arch Dermatol. 2004 Jan;140(1):33-40 [14732657.001]
  • [Cites] Cancer Metastasis Rev. 1994 Dec;13(3-4):303-8 [7712592.001]
  • [Cites] Indian J Dermatol Venereol Leprol. 2006 Sep-Oct;72(5):346-9 [17050927.001]
  • [Cites] Dermatol Surg. 1997 Mar;23(3):191-6 [9145962.001]
  • [Cites] J Cutan Laser Ther. 2001 Jun;3(2):63-6 [11798495.001]
  • [Cites] Arch Dermatol. 2004 Jul;140(7):813-6 [15262691.001]
  • [Cites] Br J Dermatol. 1968 Aug;80(8):540-2 [5675992.001]
  • [Cites] Arch Dermatol. 2002 Sep;138(9):1165-71 [12224977.001]
  • [Cites] Arch Dermatol. 2001 Mar;137(3):319-24 [11255332.001]
  • [Cites] J Am Acad Dermatol. 1994 Mar;30(3):447-51 [8113458.001]
  • [Cites] Br J Dermatol. 2004 Jul;151(1):148-56 [15270884.001]
  • [Cites] Dermatol Surg. 2004 Apr;30(4 Pt 1):517-20 [15056141.001]
  • [Cites] Br J Dermatol. 2000 Feb;142(2):338-9 [10730770.001]
  • [Cites] Australas J Dermatol. 1997 Nov;38(4):187-9 [9431711.001]
  • [Cites] J Dermatolog Treat. 2003;14 Suppl 3:15-22 [14522637.001]
  • [Cites] Dermatology. 2000;200(4):346-8 [10894974.001]
  • [Cites] Arch Dermatol. 2004 Jan;140(1):17-23 [14732655.001]
  • [Cites] Eur J Dermatol. 2005 Sep-Oct;15(5):374-81 [16172048.001]
  • [Cites] J Dermatolog Treat. 2003 Jun;14(2):99-106 [12775317.001]
  • [Cites] Arch Dermatol. 1982 May;118(5):309-11 [7082021.001]
  • [Cites] Br J Dermatol. 2000 Oct;143(4):767-72 [11069454.001]
  • [Cites] Dermatol Surg. 2001 Jun;27(6):561-4 [11442593.001]
  • [Cites] Br J Dermatol. 2005 Apr;152(4):765-72 [15840111.001]
  • [Cites] J Am Acad Dermatol. 1999 Dec;41(6):1002-7 [10570388.001]
  • [Cites] Br J Dermatol. 2006 Nov;155(5):1029-36 [17034536.001]
  • [Cites] J Am Acad Dermatol. 2006 Sep;55(3):537-8 [16908371.001]
  • [Cites] Br J Cancer. 1997;76(1):100-6 [9218740.001]
  • [Cites] Br J Dermatol. 2001 Apr;144(4):832-40 [11298545.001]
  • [Cites] Br J Dermatol. 2002 Jan;146(1):94-100 [11841372.001]
  • [Cites] Semin Arthritis Rheum. 1998 Aug;28(1):48-59 [9726336.001]
  • [Cites] Arch Dermatol. 2004 Jan;140(1):41-6 [14732659.001]
  • [Cites] Br J Dermatol. 2003 Mar;148(3):539-43 [12653747.001]
  • [Cites] Dermatol Surg. 1996 May;22(5):455-60 [8634809.001]
  • [Cites] J Invest Dermatol. 2006 Jun;126(6):1251-5 [16557235.001]
  • [Cites] J Am Acad Dermatol. 2006 May;54(5 Suppl):S218-9 [16631944.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Dec;3(12):1009-15 [16416571.001]
  • [Cites] J Am Acad Dermatol. 2007 Jan;56(1):125-43 [17190630.001]
  • [Cites] Arch Dermatol. 2004 Dec;140(12 ):1542 [15611446.001]
  • [Cites] Lancet. 2004 Nov 13-19;364(9447):1766-72 [15541449.001]
  • [Cites] Dermatol Surg. 2004 Feb;30(2 Pt 2):264-71 [14871220.001]
  • [Cites] J Invest Dermatol. 2007 Jan;127(1):116-9 [17024097.001]
  • [Cites] J Natl Cancer Inst. 2003 Aug 6;95(15):1138-49 [12902443.001]
  • [Cites] Clin Radiol. 1986 Jan;37(1):33-4 [3514075.001]
  • [Cites] Sex Transm Dis. 1993 Nov-Dec;20(6):344-5 [8108758.001]
  • [Cites] Arch Dermatol. 2003 Oct;139(10):1313-20 [14568836.001]
  • [Cites] Br J Dermatol. 2002 Dec;147(6):1227-36 [12452875.001]
  • [Cites] Cancer Res. 2000 Mar 1;60(5):1306-11 [10728691.001]
  • [Cites] Clin Dermatol. 1997 May-Jun;15(3):335-47 [9255440.001]
  • [Cites] Clin Ther. 2002 Jun;24(6):990-1000 [12117087.001]
  • [Cites] J Am Acad Dermatol. 2001 May;44(5):807-13 [11312429.001]
  • (PMID = 17429585.001).
  • [ISSN] 0017-8470
  • [Journal-full-title] Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  • [ISO-abbreviation] Hautarzt
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


43. Shokrollahi K, Marsden NJ, Whitaker IS, James W, Murison MS: Basal cell carcinoma treated successfully with combined CO2 laser and photodynamic therapy in a renal transplant patient: a case report. Cases J; 2009;2:7920
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma treated successfully with combined CO2 laser and photodynamic therapy in a renal transplant patient: a case report.
  • A significant number of patients present with lesions needing excision at multiple outpatient follow-up visits.
  • For basal cell carcinoma, we have recently described how combining CO(2) laser with Photodynamic therapy greatly increases the efficacy of long-term tumour clearance compared with each modality alone.
  • This strategy allows simple and effective treatment of multiple lesions simultaneously, avoidance of numerous operations, avoidance of non-essential outpatient appointments that result in booking furthers visits for treatment, whilst facilitating diagnostic biopsies of potentially malignant lesions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 1991 May;24(5 Pt 1):715-9 [1869642.001]
  • [Cites] Arch Dermatol. 1999 Oct;135(10):1177-83 [10522664.001]
  • [Cites] Br J Dermatol. 1999 Sep;141(3):415-23 [10583044.001]
  • [Cites] Br J Dermatol. 2001 Mar;144(3):567-74 [11260016.001]
  • [Cites] Br J Dermatol. 2005 Sep;153(3):574-8 [16120145.001]
  • [Cites] Br J Dermatol. 2006 Apr;154(4):790-1 [16536838.001]
  • [Cites] Ann Plast Surg. 2007 Nov;59(5):484-8 [17992139.001]
  • [Cites] Hum Pathol. 2007 Feb;38(2):351-8 [17134737.001]
  • [Cites] JAMA. 2006 Dec 20;296(23):2823-31 [17179459.001]
  • [Cites] Br J Dermatol. 2007 Feb;156(2):320-8 [17223873.001]
  • [Cites] Cochrane Database Syst Rev. 2007;(1):CD003412 [17253489.001]
  • [Cites] Int J Cancer. 2007 Nov 1;121(9):2105-8 [17640064.001]
  • [Cites] Acta Derm Venereol. 2006;86(1):25-8 [16585985.001]
  • (PMID = 19918437.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2769387
  •  go-up   go-down


44. Kantrow SM, Ivan D, Williams MD, Prieto VG, Lazar AJ: Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol; 2007 Oct;29(5):462-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus.
  • Nevus sebaceus of Jadassohn is a hamartoma of multiple skin structures.
  • Many neoplasms have been reported to arise in association with nevus sebaceus, most commonly trichoblastoma/basal cell carcinoma and syringocystadenoma papilliferum.
  • We report a case of a 66-year-old woman with an adenocarcinoma as well as multiple neoplastic proliferations arising in a long standing nevus sebaceus on the scalp, with subsequent occipital neck metastatic disease.
  • Other portions demonstrated a high-grade neoplasm with prominent nuclear atypia and a solid pattern of growth resembling high-grade breast carcinoma.
  • [MeSH-minor] Aged. Cell Proliferation. Female. Humans. Membrane Proteins / metabolism. Mucin-1 / metabolism. Receptor, ErbB-2 / metabolism


45. Argenziano G, Mordente I, Ferrara G, Sgambato A, Annese P, Zalaudek I: Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol; 2008 Aug;159(2):331-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective analysis of 600 lesions from 405 patients (aged 6-79 years) was performed to examine patient compliance and clinical outcome in patients with multiple atypical melanocytic lesions undergoing sequential dermoscopy imaging during short-, medium- or long-term follow-up.
  • RESULTS: In a median follow-up period of 23 months, 54 (9%) lesions were excised, revealing 12 early melanomas (occurring in 3% of monitored patients), one basal cell carcinoma and 41 melanocytic naevi.
  • CONCLUSIONS: In patients with multiple naevi sequential dermoscopy imaging is a useful strategy to avoid missing melanomas while minimizing unnecessary excision of benign lesions.


46. Tanori M, Mancuso M, Pasquali E, Leonardi S, Rebessi S, Di Majo V, Guilly MN, Giangaspero F, Covelli V, Pazzaglia S, Saran A: PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma. Carcinogenesis; 2008 Oct;29(10):1911-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma.
  • Humans and mice with mutated Ptc1 are prone to medulloblastoma and basal cell carcinoma (BCC), both tumors showing dependence on radiation damage for rapid onset and high penetrance.
  • In addition to increased formation and slowed down kinetics of disappearance of gamma-H2AX foci, we observed increased apoptosis in PARP-1-deficient granule cell progenitors after irradiation.
  • Double-mutant mice were also strikingly more susceptible to BCC, with >50% of animals developing multiple, large, infiltrative tumors within 30 weeks of age.
  • [MeSH-major] Carcinoma, Basal Cell / prevention & control. Medulloblastoma / prevention & control. Poly(ADP-ribose) Polymerases / physiology. Receptors, Cell Surface / physiology

  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18660545.001).
  • [ISSN] 1460-2180
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Histones; 0 / Receptors, Cell Surface; 0 / gamma-H2AX protein, mouse; 0 / patched receptors; EC 2.4.2.30 / Parp1 protein, mouse; EC 2.4.2.30 / Poly(ADP-ribose) Polymerases
  •  go-up   go-down


47. Fogel BL, Perlman S: An approach to the patient with late-onset cerebellar ataxia. Nat Clin Pract Neurol; 2006 Nov;2(11):629-35; quiz 1 p following 635
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: An 83-year-old man presented with hypertension, hyperlipidemia, and a previous basal cell carcinoma, having developed progressive worsening of his balance and difficulty walking at the age of 78 years.
  • The patient then underwent multiple evaluations for an underlying paraneoplastic process, all of which were negative, but his symptoms progressed and he remained undiagnosed for several years.

  • Genetic Alliance. consumer health - Cerebellar Ataxia.
  • Genetic Alliance. consumer health - Ataxia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17057750.001).
  • [ISSN] 1745-834X
  • [Journal-full-title] Nature clinical practice. Neurology
  • [ISO-abbreviation] Nat Clin Pract Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


48. Loncaster JA, Moore JV, Allan D, Allan E: An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy. Photodiagnosis Photodyn Ther; 2005 Jun;2(2):149-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy.
  • BACKGROUND: Gorlin Syndrome (naevoid basal cell carcinoma syndrome, NBCCS) predisposes the patient to the development of basal cell carcinomas (BCCs) throughout their life.
  • However, when numerous surgical procedures are required over time, the patient can be left with multiple disfiguring scars.
  • This study evaluates PDT as a treatment modality for Gorlin Syndrome and compares the treatment response of Gorlin-related basal cell carcinomas with that of the sporadic lesions.
  • METHODS: In this un-randomized study, basal cell carcinomas in 25 Gorlin syndrome patients (with 36 lesions) and 145 sporadic patients (with 189 lesions) were treated by photodynamic therapy, using δ-5-aminolaevulinic acid (ALA) as a photosensitizer and 100Jcm(-2) of red light (630±15nm).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25048674.001).
  • [ISSN] 1572-1000
  • [Journal-full-title] Photodiagnosis and photodynamic therapy
  • [ISO-abbreviation] Photodiagnosis Photodyn Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


49. Helpap B: [Small suggestive lesions of the prostate. Histological and immunohistochemical analyses -- report of the uropathology consultation service]. Pathologe; 2005 Nov;26(6):398-404
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To check the diagnosis of "small two- or three-gland carcinoma" we prepared new H and E sections and, when the atypical glands were no longer available, also performed immunohistochemical analyses in 1,041 cases referred to our uropathology consultation service, comparing the diagnoses supplied by the referring doctors with the final diagnoses.
  • In 61.6 of these cases histology confirmed the diagnosis of adenocarcinoma of the prostate; the diagnosis recorded when the basal cell marker was absent and the tumour marker P504S was strongly expressed was atypical microglandular proliferation or suspected carcinoma.
  • Previous diagnoses of prostatic carcinoma were confirmed in 99% of cases.
  • In this way we also confirmed a further 27.9% of cases of prostate carcinoma in the grey area of diagnoses endorsed "suggestive" or "suspected".
  • The patients concerned were thus spared multiple screening biopsies and were assigned for definitive treatment.
  • [MeSH-minor] Biopsy. Cell Division / physiology. Cell Transformation, Neoplastic / pathology. Diagnosis, Differential. Humans. Immunoenzyme Techniques. Male. Prostatic Hyperplasia / pathology. Referral and Consultation

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1995 Mar;19(3):251-60 [7532918.001]
  • [Cites] Am J Surg Pathol. 2002 Dec;26(12):1588-96 [12459625.001]
  • [Cites] Hum Pathol. 2003 Aug;34(8):792-6 [14506641.001]
  • [Cites] Urology. 1998 May;51(5):749-57; discussion 757-8 [9610588.001]
  • [Cites] Hum Pathol. 1995 Feb;26(2):223-9 [7860053.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1169-74 [12218573.001]
  • [Cites] Pathol Res Pract. 1999;195(12):795-9 [10631713.001]
  • [Cites] Am J Clin Pathol. 2004 Jan;121(1):99-107 [14750247.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1161-8 [12218572.001]
  • [Cites] Histopathology. 2004 Sep;45(3):218-25 [15330799.001]
  • [Cites] Virchows Arch. 1998 Nov;433(5):397-405 [9849853.001]
  • [Cites] Histopathology. 2004 Apr;44(4):403-4 [15049912.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):43-6 [14745723.001]
  • [Cites] Pathologe. 1996 Nov;17(6):417-24 [9082362.001]
  • [Cites] Am J Surg Pathol. 2002 Jul;26(7):926-31 [12131161.001]
  • [Cites] J Clin Pathol. 2003 Dec;56(12):892-7 [14645345.001]
  • [Cites] J Pathol. 2001 Mar;193(3):350-3 [11241415.001]
  • [Cites] Am J Surg Pathol. 2003 Aug;27(8):1128-33 [12883245.001]
  • [Cites] JAMA. 2002 Apr 3;287(13):1662-70 [11926890.001]
  • [Cites] J Urol. 2001 Aug;166(2):402-10 [11458037.001]
  • [Cites] Verh Dtsch Ges Pathol. 1999;83:162-7 [10714207.001]
  • [Cites] Am J Clin Pathol. 1997 Dec;108(6):633-40 [9384444.001]
  • [Cites] Verh Dtsch Ges Pathol. 2004;88:152-7 [16892546.001]
  • [Cites] Am J Surg Pathol. 2004 Feb;28(2):239-43 [15043314.001]
  • [Cites] Am J Clin Pathol. 2004 Aug;122(2):275-89 [15323145.001]
  • [Cites] Histopathology. 2005 Jul;47(1):1-16 [15982318.001]
  • (PMID = 16163479.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


50. Martorell A, Botella-Estrada R, Nagore E, Guillen-Barona C: Dermoscopic features of a collision tumour composed of a pigmented basal cell carcinoma and a melanoma. J Eur Acad Dermatol Venereol; 2010 Aug;24(8):982-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dermoscopic features of a collision tumour composed of a pigmented basal cell carcinoma and a melanoma.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Melanoma / pathology. Neoplasms, Multiple Primary / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20202050.001).
  • [ISSN] 1468-3083
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Netherlands
  •  go-up   go-down


51. Fien SM, Oseroff AR: Photodynamic therapy for non-melanoma skin cancer. J Natl Compr Canc Netw; 2007 May;5(5):531-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Topical PDT is indicated for treating actinic keratosis, superficial or thin non-melanoma skin cancer, including some cases of nodular basal cell carcinoma, and some cutaneous lymphomas.
  • Advantages of aminolevulinic acid/methyl aminolevulinate PDT include the possibility of simultaneous treatment of multiple tumors and large surface areas, good cosmesis, and minimal morbidity, such as bleeding, scarring, or infection.
  • [MeSH-major] Carcinoma, Basal Cell / drug therapy. Carcinoma, Squamous Cell / drug therapy. Photochemotherapy / methods. Skin Neoplasms / drug therapy
  • [MeSH-minor] Bowen's Disease / drug therapy. Humans. Keratosis / drug therapy. Light. Lymphoma, B-Cell / drug therapy. Lymphoma, T-Cell, Cutaneous / drug therapy. Photosensitizing Agents / therapeutic use

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17509255.001).
  • [ISSN] 1540-1405
  • [Journal-full-title] Journal of the National Comprehensive Cancer Network : JNCCN
  • [ISO-abbreviation] J Natl Compr Canc Netw
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01CA55791; United States / NCI NIH HHS / CA / P30CA16056
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosensitizing Agents
  • [Number-of-references] 66
  •  go-up   go-down


52. Winship IM, Dudding TE: Lessons from the skin--cutaneous features of familial cancer. Lancet Oncol; 2008 May;9(5):462-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenomatous Polyposis Coli / pathology. Basal Cell Nevus Syndrome / pathology. Carcinoma, Renal Cell / pathology. Colorectal Neoplasms, Hereditary Nonpolyposis / pathology. Disease Progression. Gene Expression Regulation, Neoplastic. Genetic Testing. Hamartoma Syndrome, Multiple / pathology. Humans. Leiomyomatosis / pathology. Multiple Endocrine Neoplasia / pathology. Multiple Endocrine Neoplasia Type 2a / pathology. Multiple Endocrine Neoplasia Type 2b / pathology. Mutation. Neurofibromatosis 1 / pathology. Neurofibromatosis 2 / pathology. Pedigree. Peutz-Jeghers Syndrome / pathology. Tuberous Sclerosis / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18452857.001).
  • [ISSN] 1474-5488
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 75
  •  go-up   go-down


53. Go JW, Oh HE, Cho HK, Kang WH, Ro BI: A case of basaloid follicular hamartoma. Ann Dermatol; 2010 May;22(2):229-31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Basaloid follicular hamartoma (BFH), uncommon rare benign neoplasm connected to the adnexal structures, presents with multiple clinical manifestations that can develop into basal cell carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Dermatol. 2005 May;44(5):361-5 [15869532.001]
  • [Cites] Arch Dermatol. 2005 Jan;141(1):60-7 [15655143.001]
  • [Cites] AMA Arch Derm Syphilol. 1952 Apr;65(4):471-6 [14902117.001]
  • [Cites] Arch Dermatol. 1993 Jul;129(7):915-7 [8323325.001]
  • [Cites] Am J Dermatopathol. 2003 Apr;25(2):130-7 [12652194.001]
  • [Cites] J Am Acad Dermatol. 1992 Aug;27(2 Pt 1):237-40 [1430363.001]
  • [Cites] J Cutan Med Surg. 2003 Sep-Oct;7(5):395-8 [14973645.001]
  • [Cites] J Am Acad Dermatol. 2003 Dec;49(6):1067-70 [14639386.001]
  • [Cites] J Am Acad Dermatol. 1993 Jul;29(1):125-9 [8315072.001]
  • (PMID = 20548923.001).
  • [ISSN] 2005-3894
  • [Journal-full-title] Annals of dermatology
  • [ISO-abbreviation] Ann Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2883435
  • [Keywords] NOTNLM ; Basaloid follicular hamartoma
  •  go-up   go-down


54. Mercader P, García-Melgares ML, Roche E, Sánchez-Carazo JL, Alegre-de Miquel V: [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors]. Actas Dermosifiliogr; 2008 Sep;99(7):532-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Colorectal Neoplasms, Hereditary Nonpolyposis / epidemiology. Muir-Torre Syndrome / epidemiology. Neoplasms, Multiple Primary / epidemiology
  • [MeSH-minor] Adenocarcinoma, Sebaceous / diagnosis. Adenocarcinoma, Sebaceous / epidemiology. Adenoma / diagnosis. Adenoma / epidemiology. Adult. Aged. Aged, 80 and over. Bowen's Disease / diagnosis. Carcinoma / diagnosis. Carcinoma / epidemiology. Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / epidemiology. Carcinoma, Squamous Cell / diagnosis. Cell Differentiation. Diagnostic Errors. Endometrial Neoplasms / diagnosis. Endometrial Neoplasms / epidemiology. Endometrial Neoplasms / genetics. Female. Follow-Up Studies. Humans. Hyperplasia. Male. Microsatellite Instability. Middle Aged. Pedigree. Retrospective Studies. Spain / epidemiology. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18682166.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


55. Litak J, Behroozan D, Binder S: Co-existing basal cell carcinoma and blue nevus in an African-American woman. J Cutan Pathol; 2009 Oct;36(10):1114-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Co-existing basal cell carcinoma and blue nevus in an African-American woman.
  • Histopathologic examination revealed a basal cell carcinoma juxtaposed to a blue nevus.
  • Interestingly, the most common types of cutaneous collision tumors include melanocytic nevus and basal cell carcinoma.
  • This is the first documented case of a basal cell carcinoma co-existing alone with a blue nevus.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Neoplasms, Multiple Primary / pathology. Nevus, Blue / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 John Wiley & Sons A/S.
  • (PMID = 19602062.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


56. Madan V, Loncaster JA, Allan D, Lear JT, Sheridan L, Leach C, Allan E: Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser. J Am Acad Dermatol; 2006 Nov;55(5 Suppl):S86-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
  • Nodular basal cell carcinomas resistant to multiple forms of treatment in two patients with nevoid basal cell carcinoma syndrome (Gorlin's syndrome) were treated with systemic porfimer sodium-based photodynamic therapy.
  • [MeSH-major] Basal Cell Nevus Syndrome / drug therapy. Carcinoma, Basal Cell / drug therapy. Photochemotherapy. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17052541.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 97067-70-4 / Dihematoporphyrin Ether
  •  go-up   go-down


57. Meibodi NT, Maleki M, Javidi Z, Nahidi Y: Clinicopathological evaluation of radiation induced basal cell carcinoma. Indian J Dermatol; 2008;53(3):137-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological evaluation of radiation induced basal cell carcinoma.
  • Basal cell carcinoma (BCC) is the most frequent carcinoma occurring at the region of the body to which radiotherapy was delivered.
  • AIM: The aim of this study was to evaluate clinical and histological aspects of basal cell carcinoma in patients with a history of radiotherapy.
  • MATERIALS AND METHODS: Medical records and microscopic slides of 80 patients with basal cell carcinoma who had received radiotherapy (1996-2006) were reviewed in pathology department of Imam Reza hospital of Mashhad, Iran.
  • Plaque was the most common clinical pattern of basal cell carcinoma.
  • Fifty one percent of the patients had pigmented and 42.5% had multiple lesions.
  • Histologically, macronodular and pigmented carcinoma were the most predominant forms of basal cell carcinoma.
  • DISCUSSION: Majority of patients had scalp involvement and multiple lesions.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 2006 Nov-Dec;26(6C):4767-70 [17214338.001]
  • [Cites] Clin Exp Dermatol. 2000 Jul;25(5):381-3 [11012589.001]
  • [Cites] J Craniomaxillofac Surg. 2005 Jun;33(3):197-200 [15878521.001]
  • [Cites] Ann Plast Surg. 2004 Dec;53(6):593-5 [15602259.001]
  • [Cites] Eur J Dermatol. 1998 Apr-May;8(3):180-2 [9649688.001]
  • [Cites] Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):187-91 [9592846.001]
  • [Cites] Tex Med. 1997 Jul;93(7):57-9 [9226992.001]
  • [Cites] J Natl Cancer Inst. 1996 Dec 18;88(24):1848-53 [8961975.001]
  • [Cites] Radiat Res. 1991 Mar;125(3):318-25 [2000456.001]
  • [Cites] Radiat Res. 1984 Oct;100(1):192-204 [6494429.001]
  • [Cites] Cancer Radiother. 2004 Aug;8(4):270-3 [15450522.001]
  • [Cites] Eur J Dermatol. 2004 May-Jun;14(3):182-5 [15246946.001]
  • [Cites] Cancer Radiother. 2004 Apr;8(2):81-7 [15063875.001]
  • [Cites] Dermatol Surg. 2003 Dec;29(12):1233-5 [14725670.001]
  • [Cites] Radiat Res. 2002 Apr;157(4):410-8 [11893243.001]
  • [Cites] Dermatol Surg. 2001 Jul;27(7):667-9 [11442620.001]
  • [Cites] Presse Med. 2006 Jan;35(1 Pt 1):55-7 [16462665.001]
  • (PMID = 19882013.001).
  • [ISSN] 1998-3611
  • [Journal-full-title] Indian journal of dermatology
  • [ISO-abbreviation] Indian J Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2763736
  • [Keywords] NOTNLM ; Basal cell carcinoma / basal cell epithelioma / radiotherapy
  •  go-up   go-down


58. Carón RW, Yacoub A, Mitchell C, Zhu X, Hong Y, Sasazuki T, Shirasawa S, Hagan MP, Grant S, Dent P: Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells. Cell Cycle; 2005 Mar;4(3):456-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
  • The abilities of mutated active K-RAS and H-RAS proteins, in an isogenic human carcinoma cell system, to modulate the activity of signaling pathways and cell cycle progression following exposure to ionizing radiation is largely unknown.
  • Loss of K-RAS D13 expression in parental HCT116 colorectal carcinoma cells blunted basal ERK1/2, AKT and JNK1/2 activity by -70%.
  • Expression of H-RAS V12 in HCT116 cells lacking an activated RAS molecule (H-RAS V12 cells) restored basal ERK1/2 and AKT activity to that observed in parental cells, but did not restore or alter basal JNK1/2 and p38 activity.
  • Collectively, our findings argue that the coordinated activation of multiple signaling pathways, in particular ERK1/2 and JNK1/2, by radiation is required to elevate the expression of G1 and S phase cyclin proteins and to promote S phase entry in human colon carcinoma cells expressing wild type p53.
  • In HCT116 cells H-RAS V12 promotes hMDM2 expression after radiation exposure which correlates with reduced p53 expression and increased cell survival.
  • [MeSH-minor] Alleles. Blotting, Western. Cell Cycle. Cell Line, Tumor / radiation effects. Cell Survival. Electrophoresis, Polyacrylamide Gel. Gene Deletion. Genes, ras. Humans. Mutation. Phosphatidylinositol 3-Kinases / metabolism. Propidium / pharmacology. Proto-Oncogene Proteins c-mdm2 / metabolism. RNA, Messenger / metabolism. Radiation, Ionizing. Signal Transduction. Time Factors

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15655348.001).
  • [ISSN] 1551-4005
  • [Journal-full-title] Cell cycle (Georgetown, Tex.)
  • [ISO-abbreviation] Cell Cycle
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01-CA72955; United States / NCI NIH HHS / CA / P30 CA16059; United States / NCI NIH HHS / CA / R01-CA63753; United States / NCI NIH HHS / CA / R01-CA72955; United States / NCI NIH HHS / CA / R01-CA77141; United States / NCI NIH HHS / CA / R01-CA88906; United States / NIDDK NIH HHS / DK / R01-DK52825
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 36015-30-2 / Propidium; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.24 / Mitogen-Activated Protein Kinase 9; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 8; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down


59. Malvehy J, Puig S, Martí-Laborda RM: Dermoscopy of skin lesions in two patients with xeroderma pigmentosum. Br J Dermatol; 2005 Feb;152(2):271-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To describe the clinical and dermoscopic features of different benign and malignant lesions [focusing on malignant melanoma, basal cell carcinoma (BCC) and benign melanocytic naevi] in two patients with XP.
  • RESULTS: Multiple skin tumours showing some degree of pigmentation were detected in the patients.
  • [MeSH-minor] Adolescent. Adult. Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / etiology. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Melanoma / diagnosis. Melanoma / etiology. Nevus, Pigmented / diagnosis. Nevus, Pigmented / etiology

  • Genetic Alliance. consumer health - Xeroderma pigmentosum.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15727638.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA83115
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  •  go-up   go-down


60. Calzavara-Pinton P, Leali C, Venturini M, Sala R, Zane C: Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene. Eur J Dermatol; 2007 Jul-Aug;17(4):341-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of multiple basal cell carcinomas in mycosis fungoides treated with oral bexarotene.
  • [MeSH-major] Anticarcinogenic Agents / administration & dosage. Carcinoma, Basal Cell / drug therapy. Mycosis Fungoides / drug therapy. Neoplasms, Multiple Primary / drug therapy. Skin Neoplasms / drug therapy. Tetrahydronaphthalenes / administration & dosage

  • Genetic Alliance. consumer health - Mycosis fungoides.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17540649.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Anticarcinogenic Agents; 0 / Tetrahydronaphthalenes; A61RXM4375 / bexarotene
  •  go-up   go-down


61. Shams PN, Olver JM: A case of cutaneous collision tumour: the importance of photographic documentation and large incisional biopsy. Eye (Lond); 2006 Nov;20(11):1324-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Carcinoma, Adenoid Cystic / pathology. Carcinoma, Basal Cell / pathology. Eyelid Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16575419.001).
  • [ISSN] 0950-222X
  • [Journal-full-title] Eye (London, England)
  • [ISO-abbreviation] Eye (Lond)
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  •  go-up   go-down


62. Baykal C, Buyukbabani N, Yazganoglu KD, Saglik E: [Tumors associated with nevus sebaceous]. J Dtsch Dermatol Ges; 2006 Jan;4(1):28-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Various benign and malignant neoplasms can develop in association with NS, the most common being trichoblastoma, syringocystadenoma papilliferum, viral warts and basal cell carcinoma (BCC).
  • [MeSH-major] Cell Transformation, Neoplastic / pathology. Neoplasms, Multiple Primary / diagnosis. Neoplasms, Second Primary / diagnosis. Nevus / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma, Basal Cell / diagnosis. Carcinoma, Basal Cell / pathology. Facial Neoplasms / diagnosis. Facial Neoplasms / pathology. Female. Humans. Male. Middle Aged. Scalp / pathology. Skin / pathology


63. Olejniczak I, Kozłowski Z, Dabrowska K, Lukomski M: [Tumors of the parotid gland--management and results of surgical treatment]. Otolaryngol Pol; 2008;62(4):446-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The rest histological type were Whartin's tumor, myoepithelial and basal cell adenoma respectively.
  • Malignant neoplasms were diagnosed in 16 patients, most commonly mucoepidermoid carcinoma.
  • [MeSH-major] Neoplasms, Multiple Primary / epidemiology. Neoplasms, Multiple Primary / ultrasonography. Parotid Neoplasms / epidemiology. Parotid Neoplasms / ultrasonography
  • [MeSH-minor] Adenoma / epidemiology. Adenoma / ultrasonography. Adult. Aged. Carcinoma, Mucoepidermoid / epidemiology. Carcinoma, Mucoepidermoid / ultrasonography. Female. Humans. Male. Middle Aged. Myoepithelioma / epidemiology. Myoepithelioma / ultrasonography. Poland. Retrospective Studies. Risk Factors. Salivary Gland Neoplasms / epidemiology. Salivary Gland Neoplasms / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18837221.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


64. Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, Lehmann A, Friedmann PS, Emmert S, Gratchev A, Lachlan K, Lucassan A, Baker CC, Kraemer KH: Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat; 2006 Nov;27(11):1092-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Defects in the xeroderma pigmentosum type B (XPB) gene (ERCC3), a DNA helicase involved in nucleotide excision repair (NER) and an essential subunit of the basal transcription factor, TFIIH, have been described in only three families.
  • All XP-B cells had reduced NER and post-ultraviolet (UV) cell viability.
  • [MeSH-minor] Abnormalities, Multiple / genetics. Adult. Alternative Splicing. Carcinoma, Basal Cell / genetics. Cell Survival / radiation effects. DNA Repair. Demyelinating Diseases / genetics. Eye Neoplasms / genetics. Female. Gene Expression. Genome, Human. Heterozygote. Humans. Male. Melanoma / genetics. Middle Aged. Mutation. Nuclear Family. Phenotype. Photosensitivity Disorders / genetics. Polymorphism, Genetic. RNA / biosynthesis. Ultraviolet Rays / adverse effects


65. Kaune KM, Haas E, Buhl T, Schön MP, Zutt M: Multiple basal cell carcinomas arising in radiotherapy-treated nevus flammeus: early detection facilitated by 595-nm pulsed dye laser. Eur J Dermatol; 2010 Jul-Aug;20(4):510-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple basal cell carcinomas arising in radiotherapy-treated nevus flammeus: early detection facilitated by 595-nm pulsed dye laser.
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Lasers, Dye / therapeutic use. Low-Level Light Therapy. Port-Wine Stain / radiotherapy. Skin Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20403798.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] France
  •  go-up   go-down


66. Gyurova MS, Stancheva MZ, Arnaudova MN, Yankova RK: Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas. Dermatol Online J; 2006;12(3):25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas.
  • An 82-year-old female with with multiple basal cell carcinomas is presented.
  • We injected intralesional bleomycin to eight new histologically proven basal cell cancers.
  • [MeSH-major] Antimetabolites, Antineoplastic / administration & dosage. Bleomycin / administration & dosage. Carcinoma, Basal Cell / drug therapy. Neoplasms, Second Primary / drug therapy. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638439.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 11056-06-7 / Bleomycin
  •  go-up   go-down


67. Rodriguez J, Nonaka D, Kuhn E, Reichel M, Rosai J: Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature. Am J Dermatopathol; 2005 Aug;27(4):314-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature.
  • We describe two cases of a malignant cutaneous neoplasm with combined phenotypical features of high-grade basal cell carcinoma and malignant melanoma.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Melanoma / pathology. Neoplasms, Multiple Primary / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16121052.001).
  • [ISSN] 0193-1091
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


68. Alpsoy E, Durusoy C, Ozbilim G, Karpuzoğlu G, Yilmaz E: Nevus comedonicus syndrome: a case associated with multiple basal cell carcinomas and a rudimentary toe. Int J Dermatol; 2005 Jun;44(6):499-501
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nevus comedonicus syndrome: a case associated with multiple basal cell carcinomas and a rudimentary toe.
  • [MeSH-major] Carcinoma, Basal Cell / diagnosis. Nevus, Pigmented / diagnosis. Skin Neoplasms / diagnosis. Toes / abnormalities

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. ALL-TRANS-RETINOIC ACID .
  • Hazardous Substances Data Bank. BENZOYL PEROXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15941441.001).
  • [ISSN] 0011-9059
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dermatologic Agents; 5688UTC01R / Tretinoin; 74469-00-4 / Amoxicillin-Potassium Clavulanate Combination; W9WZN9A0GM / Benzoyl Peroxide
  •  go-up   go-down


69. King R, Lyons J, Meyers AL, Googe PB, Page RN, Gupta VK: Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases. J Cutan Pathol; 2007 Aug;34(8):629-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases.
  • The juxtaposition of malignant melanoma and basal cell carcinoma (BCC) has been rarely reported in case reports, with most cases describing melanoma in situ and BCC.
  • Immunohistochemical studies delineated the two cell populations.
  • In addition, one patient presented with multiple cutaneous metastases, all simulating blue nevi.
  • [MeSH-major] Carcinoma, Basal Cell / secondary. Melanoma / pathology. Neoplasms, Multiple Primary / pathology. Nevus, Blue / secondary. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17640233.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


70. Cobourne MT, Xavier GM, Depew M, Hagan L, Sealby J, Webster Z, Sharpe PT: Sonic hedgehog signalling inhibits palatogenesis and arrests tooth development in a mouse model of the nevoid basal cell carcinoma syndrome. Dev Biol; 2009 Jul 01;331(1):38-49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sonic hedgehog signalling inhibits palatogenesis and arrests tooth development in a mouse model of the nevoid basal cell carcinoma syndrome.
  • Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant or spontaneous disorder characterized by multiple cutaneous basal cell carcinomas, odontogenic keratocysts, skeletal anomalies and facial dysmorphology, including cleft lip and palate.
  • We have investigated the molecular basis of craniofacial defects seen in NBCCS using a transgenic mouse model expressing Shh in basal epithelium under a Keratin-14 promoter.
  • Significantly, increased Hedgehog signal transduction in these mice can influence cell fate within the craniofacial region.
  • In contrast, high levels of Shh in odontogenic epithelium arrests tooth development at the bud stage, secondary to a lack of cell proliferation in this region.
  • [MeSH-major] Basal Cell Nevus Syndrome / genetics. Hedgehog Proteins / genetics. Tooth / growth & development
  • [MeSH-minor] Abnormalities, Multiple / genetics. Animals. Cell Death. Cell Division. Chromosome Mapping. Chromosomes, Human, Pair 9. Cleft Palate / genetics. DNA Primers. Disease Models, Animal. Humans. In Situ Hybridization. Keratin-14 / genetics. Medulloblastoma / pathology. Mice. Mice, Transgenic. Promoter Regions, Genetic

  • Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2007 Jun;117(6):1575-84 [17525797.001]
  • [Cites] Science. 2007 Jul 20;317(5836):372-6 [17641202.001]
  • [Cites] Nature. 2007 Nov 29;450(7170):717-20 [18046410.001]
  • [Cites] Clin Cancer Res. 2008 Feb 15;14(4):971-6 [18281528.001]
  • [Cites] Med Oral Patol Oral Cir Bucal. 2008 Jun;13(6):E338-43 [18521051.001]
  • [Cites] Genes Dev. 2005 Mar 1;19(5):626-41 [15741323.001]
  • [Cites] Curr Biol. 2001 Apr 17;11(8):601-7 [11369205.001]
  • [Cites] Curr Biol. 2001 Apr 17;11(8):608-13 [11369206.001]
  • [Cites] Cell. 2001 Jun 15;105(6):781-92 [11440720.001]
  • [Cites] Genes Dev. 2001 Dec 1;15(23):3059-87 [11731473.001]
  • [Cites] J Dent Res. 2001 Nov;80(11):1974-9 [11759005.001]
  • [Cites] Development. 2002 Sep;129(17):4135-46 [12163415.001]
  • [Cites] Nature. 2002 Aug 22;418(6900):892-7 [12192414.001]
  • [Cites] Development. 2002 Oct;129(20):4753-61 [12361967.001]
  • [Cites] Development. 2002 Dec;129(23):5323-37 [12403705.001]
  • [Cites] J Cell Sci. 2002 Dec 1;115(Pt 23):4393-7 [12414986.001]
  • [Cites] Curr Top Dev Biol. 2003;53:1-114 [12509125.001]
  • [Cites] J Invest Dermatol. 2003 Sep;121(3):478-81 [12925203.001]
  • [Cites] Nature. 2003 Nov 6;426(6962):83-7 [14603322.001]
  • [Cites] Dev Cell. 2004 Jan;6(1):103-15 [14723851.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Mar;33(2):117-24 [15050066.001]
  • [Cites] Genes Dev. 2004 Apr 15;18(8):937-51 [15107405.001]
  • [Cites] Development. 2004 Jun;131(12):2875-85 [15151988.001]
  • [Cites] J Clin Invest. 2004 Jun;113(12):1692-700 [15199404.001]
  • [Cites] J Clin Invest. 2004 Aug;114(4):485-94 [15314685.001]
  • [Cites] Nature. 2004 Sep 2;431(7004):76-80 [15300262.001]
  • [Cites] Development. 2004 Oct;131(20):5009-19 [15371305.001]
  • [Cites] J Craniofac Genet Dev Biol. 1983;3(2):159-77 [6619276.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Mar;86(5):1563-7 [2466292.001]
  • [Cites] Dentomaxillofac Radiol. 1987;16(2):99-103 [3333752.001]
  • [Cites] J Med Genet. 1993 Jun;30(6):460-4 [8326488.001]
  • [Cites] Int J Dev Biol. 1993 Sep;37(3):451-8 [8292539.001]
  • [Cites] Am J Med Genet. 1994 Apr 15;50(3):282-90 [8042673.001]
  • [Cites] Dermatol Clin. 1995 Jan;13(1):113-25 [7712637.001]
  • [Cites] Dev Biol. 1995 Nov;172(1):126-38 [7589793.001]
  • [Cites] Development. 1996 Jan;122(1):121-9 [8565823.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):301-12 [8595881.001]
  • [Cites] Science. 1996 Jun 14;272(5268):1668-71 [8658145.001]
  • [Cites] Cell. 1996 Jun 14;85(6):841-51 [8681379.001]
  • [Cites] Nature. 1996 Oct 3;383(6599):407-13 [8837770.001]
  • [Cites] Nat Genet. 1996 Nov;14(3):353-6 [8896571.001]
  • [Cites] Nat Genet. 1996 Nov;14(3):357-60 [8896572.001]
  • [Cites] Cell. 1996 Nov 1;87(3):553-63 [8898207.001]
  • [Cites] Nature. 1996 Nov 14;384(6605):129-34 [8906787.001]
  • [Cites] Am J Hum Genet. 1997 Jan;60(1):21-6 [8981943.001]
  • [Cites] Development. 1997 Jan;124(1):113-23 [9006072.001]
  • [Cites] Am J Med Genet. 1997 Mar 31;69(3):299-308 [9096761.001]
  • [Cites] Science. 1997 May 2;276(5313):817-21 [9115210.001]
  • [Cites] Science. 1997 Jul 11;277(5323):228-31 [9211849.001]
  • [Cites] Science. 1997 Jul 11;277(5323):232-5 [9211850.001]
  • [Cites] Dev Biol. 1997 Jul 1;187(1):25-35 [9224671.001]
  • [Cites] Cleft Palate Craniofac J. 1997 Jul;34(4):342-50 [9257026.001]
  • [Cites] Science. 1997 Aug 22;277(5329):1109-13 [9262482.001]
  • [Cites] Development. 1998 Aug;125(15):2803-11 [9655803.001]
  • [Cites] Nature. 1999 Feb 18;397(6720):617-21 [10050855.001]
  • [Cites] Development. 1999 Nov;126(21):4873-84 [10518503.001]
  • [Cites] N Engl J Med. 1960 May 5;262:908-12 [13851319.001]
  • [Cites] Development. 2000 Apr;127(8):1593-605 [10725236.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4520-4 [10781055.001]
  • [Cites] Development. 2000 Nov;127(22):4775-85 [11044393.001]
  • [Cites] Science. 2000 Dec 22;290(5500):2295-8 [11125140.001]
  • [Cites] Development. 2005 Jul;132(13):3103-11 [15930098.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11325-30 [16061793.001]
  • [Cites] Dev Biol. 2005 Sep 15;285(2):490-5 [16109396.001]
  • [Cites] Nature. 2005 Oct 13;437(7061):1018-21 [16136078.001]
  • [Cites] PLoS Genet. 2005 Oct;1(4):e53 [16254602.001]
  • [Cites] Dev Biol. 2005 Nov 15;287(2):378-89 [16229832.001]
  • [Cites] Gene Expr Patterns. 2006 Jan;6(2):206-12 [16168717.001]
  • [Cites] Cleft Palate Craniofac J. 2006 Jan;43(1):21-9 [16405370.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):33-8 [16371461.001]
  • [Cites] Hum Mutat. 2006 Mar;27(3):215-9 [16419085.001]
  • [Cites] Mol Cell Biol. 2006 May;26(9):3365-77 [16611981.001]
  • [Cites] Dev Cell. 2006 May;10(5):647-56 [16647304.001]
  • [Cites] Mol Cell Biol. 2006 Jun;26(11):4316-26 [16705181.001]
  • [Cites] Dev Biol. 2007 Jan 15;301(2):309-26 [16942766.001]
  • [Cites] Cell Cycle. 2007 Jan 15;6(2):156-9 [17245127.001]
  • [Cites] Genes Dev. 2007 May 15;21(10):1231-43 [17504940.001]
  • [Cites] Genes Dev. 2007 May 15;21(10):1244-57 [17504941.001]
  • (PMID = 19394325.001).
  • [ISSN] 1095-564X
  • [Journal-full-title] Developmental biology
  • [ISO-abbreviation] Dev. Biol.
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0200709; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Hedgehog Proteins; 0 / Keratin-14; 0 / SHH protein, human; 0 / Shh protein, mouse
  • [Other-IDs] NLM/ PMC2696601
  •  go-up   go-down


71. Puri T, Gunabushanam G, Sharma R, Kumar S, Julka PK: Extensive bone metastases from basal cell carcinoma of the eye. Singapore Med J; 2006 Sep;47(9):811-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extensive bone metastases from basal cell carcinoma of the eye.
  • The incidence of metastases from basal cell carcinoma is rare.
  • We report a 66-year-old woman who had basal cell carcinoma of the outer canthus of the left eye.
  • Four months later, she developed rapidly-progressive multiple skeletal metastases and died soon after.
  • [MeSH-major] Bone Neoplasms / secondary. Carcinoma, Basal Cell / pathology. Eye Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16924365.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


72. Lee DA, Grossman ME, Schneiderman P, Celebi JT: Genetics of skin appendage neoplasms and related syndromes. J Med Genet; 2005 Nov;42(11):811-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reviews the clinical and genetic aspects of inherited syndromes that are characterised by skin appendage neoplasms, including Cowden syndrome, Birt-Hogg-Dube syndrome, naevoid basal cell carcinoma syndrome, generalised basaloid follicular hamartoma syndrome, Bazex syndrome, Brooke-Spiegler syndrome, familial cylindromatosis, multiple familial trichoepitheliomas, and Muir-Torre syndrome.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Transplantation. 2004 Feb 27;77(4):574-9 [15084938.001]
  • [Cites] Trends Mol Med. 2004 Mar;10(3):136-41 [15102357.001]
  • [Cites] J Med Genet. 2004 May;41(5):323-6 [15121767.001]
  • [Cites] Mol Cancer. 2003 Dec 12;2:41 [14672538.001]
  • [Cites] Br J Surg. 1967 Mar;54(3):191-5 [6020987.001]
  • [Cites] J Med Genet. 1968 Mar;5(1):29-35 [5653864.001]
  • [Cites] Arch Dermatol. 1968 Nov;98(5):549-51 [5684233.001]
  • [Cites] Arch Dermatol. 1969 Apr;99(4):478-93 [4238829.001]
  • [Cites] Arch Dermatol. 1970 Dec;102(6):654-5 [5501907.001]
  • [Cites] Cancer. 1974 Mar;33(3):835-6 [4815585.001]
  • [Cites] J Invest Dermatol. 1974 Aug;63(2):212-8 [4843452.001]
  • [Cites] Arch Dermatol. 1974 Sep;110(3):473-4 [4375438.001]
  • [Cites] Br J Plast Surg. 1975 Oct;28(4):331-4 [1191881.001]
  • [Cites] Arch Dermatol. 1977 Dec;113(12):1674-7 [596896.001]
  • [Cites] Cancer. 1978 Jun;41(6):2393-8 [657103.001]
  • [Cites] Cancer. 1979 Dec;44(6):2294-305 [509397.001]
  • [Cites] Clin Exp Dermatol. 1983 Nov;8(6):603-12 [6661824.001]
  • [Cites] J Cutan Pathol. 1984 Oct;11(5):331-7 [6512062.001]
  • [Cites] Br J Dermatol. 1985 Sep;113(3):295-301 [4063166.001]
  • [Cites] Clin Genet. 1986 Mar;29(3):222-33 [3698331.001]
  • [Cites] Medicine (Baltimore). 1987 Mar;66(2):98-113 [3547011.001]
  • [Cites] Br J Plast Surg. 1987 Sep;40(5):528-31 [3676586.001]
  • [Cites] Ann Neurol. 1991 May;29(5):517-23 [1859181.001]
  • [Cites] J Am Acad Dermatol. 1991 May;24(5 Pt 1):715-9 [1869642.001]
  • [Cites] Lancet. 1992 Mar 7;339(8793):581-2 [1347096.001]
  • [Cites] Ann Dermatol Venereol. 1992;119(10):746-8 [1338355.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1618-23 [7688655.001]
  • [Cites] J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):189-206 [10906638.001]
  • [Cites] Cancer Res. 2000 Aug 1;60(15):4085-92 [10945614.001]
  • [Cites] J Med Genet. 2000 Nov;37(11):828-30 [11073535.001]
  • [Cites] J Am Acad Dermatol. 2000 Dec;43(6):1120-2 [11100034.001]
  • [Cites] J Invest Dermatol. 2001 Feb;116(2):246-53 [11180000.001]
  • [Cites] Dermatol Surg. 2001 Jan;27(1):67-70 [11231249.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):757-62 [11257109.001]
  • [Cites] Lancet. 2001 Jul 21;358(9277):210-1 [11476841.001]
  • [Cites] Oncogene. 2001 Aug 23;20(37):5239-42 [11526515.001]
  • [Cites] Am J Hum Genet. 2001 Oct;69(4):876-82 [11533913.001]
  • [Cites] Development. 2001 Oct;128(19):3843-53 [11585809.001]
  • [Cites] Ann Plast Surg. 2001 Jul;47(1):98-9 [11756818.001]
  • [Cites] J Am Acad Dermatol. 1993 Dec;29(6):1055-6 [8245249.001]
  • [Cites] J Med Genet. 1994 Jun;31(6):458-61 [8071972.001]
  • [Cites] Genomics. 1994 Dec;24(3):516-26 [7713503.001]
  • [Cites] J Am Acad Dermatol. 1995 Jul;33(1):90-104 [7601953.001]
  • [Cites] J Invest Dermatol. 1995 Jul;105(1):87-91 [7615983.001]
  • [Cites] J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):199-206 [7622645.001]
  • [Cites] Nat Genet. 1995 Dec;11(4):441-3 [7493027.001]
  • [Cites] Nat Genet. 1996 May;13(1):114-6 [8673088.001]
  • [Cites] Science. 1996 Jun 14;272(5268):1668-71 [8658145.001]
  • [Cites] Cell. 1996 Jun 14;85(6):841-51 [8681379.001]
  • [Cites] Int J Dermatol. 1996 May;35(5):365-7 [8734663.001]
  • [Cites] Am J Hum Genet. 1996 Sep;59(3):736-9 [8751876.001]
  • [Cites] Am J Hum Genet. 1997 Jan;60(1):21-6 [8981943.001]
  • [Cites] J Dermatol. 1996 Nov;23(11):821-4 [8990706.001]
  • [Cites] Science. 1997 Mar 28;275(5308):1943-7 [9072974.001]
  • [Cites] Nat Genet. 1997 Apr;15(4):356-62 [9090379.001]
  • [Cites] Nat Genet. 1997 May;16(1):64-7 [9140396.001]
  • [Cites] Hum Pathol. 1998 Jan;29(1):47-53 [9445133.001]
  • [Cites] Hum Mol Genet. 1998 Mar;7(3):507-15 [9467011.001]
  • [Cites] Lupus. 1998;7(3):207-9 [9607646.001]
  • [Cites] Am J Hum Genet. 1998 Jul;63(1):63-70 [9634524.001]
  • [Cites] J Med Genet. 1999 May;36(5):360-4 [10353779.001]
  • [Cites] Hum Mol Genet. 1999 Aug;8(8):1461-72 [10400993.001]
  • [Cites] Am J Dermatopathol. 1999 Aug;21(4):369-74 [10446780.001]
  • [Cites] Arch Dermatol. 1999 Oct;135(10):1195-202 [10522666.001]
  • [Cites] N Engl J Med. 1960 May 5;262:908-12 [13851319.001]
  • [Cites] Dermatol Surg. 2000 Feb;26(2):152-4 [10691946.001]
  • [Cites] J Laryngol Otol. 1999 Aug;113(8):779-83 [10748863.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1784-9 [10815898.001]
  • [Cites] Nat Genet. 2000 Jun;25(2):160-5 [10835629.001]
  • [Cites] Am J Hum Genet. 2002 Apr;70(4):829-44 [11875759.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393-400 [11927500.001]
  • [Cites] Nat Rev Genet. 2002 Mar;3(3):199-209 [11972157.001]
  • [Cites] Br J Dermatol. 2002 Jun;146(6):1068-70 [12072080.001]
  • [Cites] Trends Mol Med. 2002 Jul;8(7):346-53 [12114115.001]
  • [Cites] J Invest Dermatol. 2002 Aug;119(2):527-31 [12190880.001]
  • [Cites] Cancer Cell. 2002 Aug;2(2):157-64 [12204536.001]
  • [Cites] J Cutan Pathol. 2002 Oct;29(9):529-33 [12358810.001]
  • [Cites] J Med Genet. 2002 Dec;39(12):906-12 [12471204.001]
  • [Cites] Nature. 2003 Feb 6;421(6923):639-43 [12571598.001]
  • [Cites] Am J Dermatopathol. 2003 Apr;25(2):130-7 [12652194.001]
  • [Cites] J Med Genet. 2003 May;40(5):364-7 [12746401.001]
  • [Cites] EMBO J. 2003 Jun 2;22(11):2741-51 [12773389.001]
  • [Cites] J Med Genet. 2003 Jul;40(7):511-5 [12843323.001]
  • [Cites] Cancer. 2003 Aug 1;98(3):618-24 [12879481.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):793-6 [12917689.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):797-801 [12917690.001]
  • [Cites] J Am Acad Dermatol. 2003 Oct;49(4):717-9 [14512924.001]
  • [Cites] Am J Med Genet A. 2003 Nov 15;123A(1):5-28 [14556242.001]
  • [Cites] J Invest Dermatol. 2003 Oct;121(4):732-4 [14632188.001]
  • [Cites] J Exp Med. 2003 Dec 15;198(12):1959-64 [14676304.001]
  • [Cites] J Dermatol. 2004 Jan;31(1):32-8 [14739501.001]
  • (PMID = 16272260.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / K08 AR050273
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] England
  • [Number-of-references] 95
  • [Other-IDs] NLM/ PMC1735949
  •  go-up   go-down


73. Yu M, Zloty D, Cowan B, Shapiro J, Haegert A, Bell RH, Warshawski L, Carr N, McElwee KJ: Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol; 2008 Jul;128(7):1797-805
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
  • Basal-cell carcinoma (BCC), the most common neoplasm in humans, occurs in a variety of morphological presentations.
  • Gene ontology analysis indicated that gene expression patterns of BCC subtypes in multiple biological processes showed significant variation, particularly in genes associated with the mitogen-activated protein kinase (MAPK) pathway.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Gene Expression Profiling. Skin Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18200053.001).
  • [ISSN] 1523-1747
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Wnt Proteins; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / PTGS2 protein, human
  •  go-up   go-down


74. Asplund A, Gustafsson AC, Wikonkal NM, Sela A, Leffell DJ, Kidd K, Lundeberg J, Brash DE, Pontén F: PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer. Br J Dermatol; 2005 May;152(5):868-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The PTCH tumour suppressor gene is involved in the development of nearly all basal cell carcinomas (BCCs) of the skin and a fraction of squamous cell carcinomas (SCCs).
  • A nonconservative Pro/Leu nucleotide polymorphism within PTCH exon 23 at codon 1315 was recently reported to be potentially important for the development of breast epithelial cell cancers.
  • In 260 samples from 180 Swedish patients with NMSC and a control group of 96 healthy ethnically matched volunteers, no statistically significant pairwise differences between groups were detected in the PTCH codon 1315 allelic distribution, neither was a difference seen for multiple or early onset cases of BCC in the Swedish population.
  • In contrast, the Pro/Pro genotype was frequent in seven U.S. patients having multiple independent BCCs.
  • Failure to lose Pro during the shift to phaeomelanin may be associated with an increased population risk for BCC and increased individual risk for multiple BCC.
  • [MeSH-major] Genetic Predisposition to Disease. Neoplasm Proteins / genetics. Polymorphism, Single Nucleotide. Receptors, Cell Surface / genetics. Skin Neoplasms / genetics
  • [MeSH-minor] Carcinoma, Basal Cell / genetics. Carcinoma, Squamous Cell / genetics. Codon / genetics. Genotype. Hair Color / genetics. Humans. Loss of Heterozygosity. Pilot Projects. Polymerase Chain Reaction / methods. Skin Pigmentation / genetics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15888139.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Codon; 0 / Neoplasm Proteins; 0 / Receptors, Cell Surface; 0 / patched receptors
  •  go-up   go-down


75. Huang CC, Cheng HH, Wang JL, Cheng JS, Chai KL, Fang YC, Kuo CC, Chu ST, Ho CM, Lin KL, Tsai JY, Jan CR: Effects of Antrodia camphorata extracts on the viability, apoptosis, [Ca2+]i, and MAPKs phosphorylation of OC2 human oral cancer cells. Chin J Physiol; 2009 Jun 30;52(3):128-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AC at a concentration of 25 microM induced an increase in cell viability, but AC at concentrations > or = 50 microg/ml decreased viability in a concentration-dependent manner.
  • AC (25 microg/ml) did not alter basal [Ca2+]i, but decreased the [Ca2+]i increases induced by ATP, bradykinin, histamine and thapsigargin.
  • ATP, bradykinin, and histamine increased cell viability whereas thapsigargin decreased it.
  • Collectively, for OC2 cells, AC exerted multiple effects on their viability and [Ca2+]i, induced their ERK and JNK MAPK phosphorylation, and probably evoked their apoptosis.
  • [MeSH-major] Antrodia. Apoptosis / drug effects. Calcium / metabolism. Carcinoma, Squamous Cell / pathology. Mitogen-Activated Protein Kinase Kinases / metabolism. Mouth Neoplasms / pathology. Plant Extracts / pharmacology
  • [MeSH-minor] Cell Line, Tumor. Cell Survival / drug effects. Extracellular Signal-Regulated MAP Kinases / metabolism. Humans. MAP Kinase Kinase 4 / metabolism. Phosphorylation / drug effects. p38 Mitogen-Activated Protein Kinases / metabolism

  • Genetic Alliance. consumer health - Oral cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19777798.001).
  • [ISSN] 0304-4920
  • [Journal-full-title] The Chinese journal of physiology
  • [ISO-abbreviation] Chin J Physiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 0 / Plant Extracts; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 2.7.11.24 / p38 Mitogen-Activated Protein Kinases; EC 2.7.12.2 / MAP Kinase Kinase 4; EC 2.7.12.2 / Mitogen-Activated Protein Kinase Kinases; SY7Q814VUP / Calcium
  •  go-up   go-down


76. Rybka MO, Cintra ML, de Souza EM, Metze K: Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy. Int J Dermatol; 2008 Dec;47(12):1240-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy.
  • BACKGROUND: The dermal dendritic cell (DC) is considered to be an important component of the host defense against basal cell carcinomas (BCCs).
  • RESULTS: In nonaggressive BBCs, a multiple linear regression showed that a higher DC density was associated with an increased number of myofibroblasts, smaller tumors and those located on the face.
  • [MeSH-major] Adjuvants, Immunologic / administration & dosage. Aminoquinolines / administration & dosage. Antineoplastic Agents / administration & dosage. Carcinoma, Basal Cell / pathology. Langerhans Cells / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Administration, Topical. Adult. Aged. Aged, 80 and over. Cell Count. Facial Neoplasms / drug therapy. Facial Neoplasms / pathology. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19126008.001).
  • [ISSN] 1365-4632
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adjuvants, Immunologic; 0 / Aminoquinolines; 0 / Antineoplastic Agents; 99011-02-6 / imiquimod
  •  go-up   go-down


77. Ramos C, Ojeda D, Cohn D, Wohllk N: [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience]. Rev Med Chil; 2005 Sep;133(9):1029-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].
  • AIM: To evaluate the histological findings and the effects of the prophylactic total thyroidectomy in first-degree relatives of Chilean patients with multiple endocrine neoplasia type 2 (MEN 2) based on the Ret proto-oncogene analysis.
  • Of these, 16 either with C cell hyperplasia (CCH) or microscopic medullary thyroid carcinoma (MTC) were selected for the final analysis.
  • A significant correlation was observed between basal preoperative serum calcitonin/tumor size (r = 0.53, P < 0.05) and age/tumor size (r = 0.56, P < 0.03), but not between basal preoperative serum calcitonin and age.
  • [MeSH-major] Carcinoma, Medullary / prevention & control. Multiple Endocrine Neoplasia Type 2a / surgery. Proto-Oncogene Proteins c-ret / genetics. Thyroid Neoplasms / prevention & control. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16311694.001).
  • [ISSN] 0034-9887
  • [Journal-full-title] Revista médica de Chile
  • [ISO-abbreviation] Rev Med Chil
  • [Language] spa
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Chile
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-ret
  •  go-up   go-down


78. Walling HW, Sniezek PJ, Friedrichs A, Christensen DR, Whitaker DC: Guiding sutures to promote optimal contraction of a large surgical defect prior to delayed grafting. Dermatol Surg; 2005 Jan;31(1):109-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mohs' excision of a neglected basal cell carcinoma on the cheek left a large defect of 54 cm2.
  • Delayed grafting was selected for the repair due to the size of the wound and the presence of multiple foci of perineural, muscle and parotid invasion.
  • [MeSH-major] Carcinoma, Basal Cell / surgery. Facial Neoplasms / surgery. Suture Techniques

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15720107.001).
  • [ISSN] 1076-0512
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Mataix J, Bañuls J, Botella R, Laredo C, Lucas A: [Brooke-Spiegler syndrome: an heterogeneous entity]. Actas Dermosifiliogr; 2006 Dec;97(10):669-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinically it is characterized by the presence of multiple cylindromas, trichoepitheliomas, and occasionally, spiradenomas.
  • Although Brooke-Spiegler syndrome, familial cylindromatosis and multiple familial trichoepithelioma were initially described as separate entities, the recently identified identical mutations in the gene of cylindromatosis suggest that they represent fenotypic variations of the same entity.
  • [MeSH-major] Carcinoma, Adenoid Cystic / genetics. Neoplasms, Basal Cell / genetics. Neoplasms, Multiple Primary / genetics. Neoplastic Syndromes, Hereditary / genetics. Skin Neoplasms / genetics. Tumor Suppressor Proteins / genetics

  • Genetic Alliance. consumer health - Brooke-Spiegler syndrome.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17173833.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / CYLD protein, human; 0 / Tumor Suppressor Proteins
  • [Number-of-references] 30
  •  go-up   go-down


80. Tanahashi J, Kashima K, Daa T, Yada N, Fujiwara S, Yokoyama S: Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid. J Cutan Pathol; 2009 Sep;36(9):983-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
  • Merkel cell carcinoma is occasionally associated with other types of cutaneous malignancies including squamous cell carcinoma, basal cell carcinoma and lentigo maligna.
  • We report a case of Merkel cell carcinoma co-existent with sebaceous carcinoma in the right upper eyelid of a 61-year-old Japanese man.
  • Two nodules were Merkel cell carcinoma and located in the proximal part of the palpebral conjunctiva.
  • The third was sebaceous carcinoma located in the distal transitional zone between the epidermis and the conjunctiva.
  • Metastatic deposits were identified in the regional lymph nodes, which solely consisted of Merkel cell carcinoma without sebaceous carcinoma.
  • [MeSH-major] Adenocarcinoma, Sebaceous / pathology. Carcinoma, Merkel Cell / pathology. Eyelid Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Sebaceous Gland Neoplasms / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19017040.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


81. Lash TL, Schmidt M, Jensen AØ, Engebjerg MC: Methods to apply probabilistic bias analysis to summary estimates of association. Pharmacoepidemiol Drug Saf; 2010 Jun;19(6):638-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Methods for application to associations adjusted for multiple covariates, such as associations from regression modeling, are rarely seen.
  • RESULTS: In example one, the adjusted odds ratio associating glucocorticoid use with the rate of basal cell carcinoma was 1.15 (95%CI 1.07, 1.25).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20535760.001).
  • [ISSN] 1099-1557
  • [Journal-full-title] Pharmacoepidemiology and drug safety
  • [ISO-abbreviation] Pharmacoepidemiol Drug Saf
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


82. Madan V, Hoban PR, Strange RC, Fryer AA, Lear JT: Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol; 2006 Jul;155(1):217-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Neoplasm Recurrence, Local / pathology. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Br J Dermatol. 2005 Nov;153(5):1078-80 [16225637.001]
  • (PMID = 16792784.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] England
  •  go-up   go-down


83. Sasaki R, Miyashita T, Matsumoto N, Fujii K, Saito K, Ando T: Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug;110(2):e41-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.
  • Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder characterized by developmental abnormalities and a predisposition to cancers.
  • Although multiple jaw tumors, such as keratocystic odontogenic tumors (KCOTs), are one of the most frequent complications in NBCCS, the molecular mechanism for how KCOTs develop in NBCCS is poorly understood.
  • [MeSH-major] Basal Cell Nevus Syndrome / complications. Basal Cell Nevus Syndrome / genetics. Mandibular Neoplasms / etiology. Maxillary Neoplasms / etiology. Odontogenic Tumors / etiology. Receptors, Cell Surface / genetics

  • Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.
  • Genetic Alliance. consumer health - Basal Cell Carcinoma, Multiple.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20659694.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Receptors, Cell Surface; 0 / patched receptors; 136601-57-5 / Cyclin D1; 68238-35-7 / Keratins
  •  go-up   go-down


84. Scalvenzi M, Francia MG, Falleti J, Balato A: Basal cell carcinoma with fibroepithelioma-like histology in a healthy child: report and review of the literature. Pediatr Dermatol; 2008 May-Jun;25(3):359-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma with fibroepithelioma-like histology in a healthy child: report and review of the literature.
  • At dermoscopic examination we observed vascular pattern with linear-irregular vessels, multiple blue-gray dots, blue-gray ovoid nests, and ulceration.
  • A diagnosis of basal cell carcinoma was made and confirmed by histopathologic examination.
  • Basal cell carcinoma occurs rarely in children and is most often associated with an underlying condition that predisposes patients to the development of malignancy that was not present in our case.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Skin / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18577044.001).
  • [ISSN] 1525-1470
  • [Journal-full-title] Pediatric dermatology
  • [ISO-abbreviation] Pediatr Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 27
  •  go-up   go-down


85. Ahmed N, Salman M, Mansoor MA: Gorlin-goltz syndrome. J Coll Physicians Surg Pak; 2007 Sep;17(9):568-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple jaw cysts are a characteristic manifestation of basal cell nevus (Gorlin) syndrome.
  • In 90% of the patients, nevoid basal cell carcinoma syndrome is associated with recurring odontogenic keratocysts.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17903410.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


86. Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D, Faussone-Pellegrini MS: Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur Urol; 2005 Oct;48(4):691-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
  • OBJECTIVE: To investigate possible changes in the expression of the transient receptor potential vanilloid type 1 (TRPV1) from normal urothelium to transitional cell carcinoma (TCC) of human bladder.
  • METHODS: Specimens from normal bladder (n=13, mean age 62 yrs), superficial TCC (n=16, mean age 62,4 yrs) and muscle invasive bladder cancer (n=12, mean age 67 yrs), were obtained by multiple cold cup and full-thickness biopsy during open surgery.
  • RESULTS: In controls, the urothelium showed a labelling whose intensity was higher in the superficial cells than in the basal and club-shaped ones.
  • In the muscle invasive TCC, a very light labelling was occasionally detected in scattered superficial cells and no labelling was present in the basal cells and in those that had invaded the muscle.
  • CONCLUSION: These data demonstrated a progressive loss of TRPV1 expression in the urothelium as TCC stage increased and cell differentiation was lower.
  • [MeSH-major] Carcinoma, Transitional Cell / chemistry. Carcinoma, Transitional Cell / pathology. TRPV Cation Channels / analysis. Urinary Bladder Neoplasms / chemistry. Urinary Bladder Neoplasms / pathology. Urothelium / chemistry

  • Genetic Alliance. consumer health - Transitional cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • Hazardous Substances Data Bank. HEMATOXYLIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15992990.001).
  • [ISSN] 0302-2838
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Fluorescent Dyes; 0 / TRPV Cation Channels; 0 / TRPV1 protein, human; TDQ283MPCW / Eosine Yellowish-(YS); YKM8PY2Z55 / Hematoxylin
  •  go-up   go-down


87. Rogers HW, Coldiron BM: A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol; 2009 Jul;61(1):96-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
  • OBJECTIVE: To estimate the costs of treating nonmelanoma skin cancers by multiple modalities based on their assigned relative value unit (RVU) values.
  • METHODS: The cost analysis was performed for the treatment of two skin cancer examples, a basal cell carcinoma (BCC) on the central cheek and a squamous cell carcinoma (SCC) on the forearm of varying sizes.
  • The effect of the loss of exemption from multiple surgery reduction on the cost of Mohs surgery is also examined.
  • Mohs surgery's recent loss of multiple surgery reduction exemption has decreased the cost of Mohs surgery by 9% to 25%.
  • [MeSH-minor] Ambulatory Surgical Procedures / economics. Aminoquinolines / economics. Aminoquinolines / therapeutic use. Carcinoma, Basal Cell / economics. Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / economics. Carcinoma, Squamous Cell / surgery. Cheek / surgery. Cost-Benefit Analysis. Curettage / economics. Frozen Sections / economics. Humans. Reconstructive Surgical Procedures / economics

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. Imiquimod .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Am Acad Dermatol. 2010 Feb;62(2):347-8 [20115957.001]
  • (PMID = 19539843.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aminoquinolines; 99011-02-6 / imiquimod
  •  go-up   go-down


88. Bauza A, Del Pozo LJ, Saus C, Martin A: Pemphigus-like lesions induced by imiquimod. Clin Exp Dermatol; 2009 Jul;34(5):e60-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Imiquimod is an immunomodifier recently approved for the treatment of superficial basal cell carcinomas (sBCC).
  • We suggest that systemic absorption of the drug or greatly increased synthesis of cytokines could explain this reaction and recommend the use of low doses of imiquimod in the treatment of large or multiple sBCCs.
  • [MeSH-minor] Carcinoma, Basal Cell / drug therapy. Female. Humans. Middle Aged. Skin Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Pemphigus.
  • MedlinePlus Health Information. consumer health - Pemphigus.
  • Hazardous Substances Data Bank. Imiquimod .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19438577.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aminoquinolines; 0 / Antineoplastic Agents; 99011-02-6 / imiquimod
  •  go-up   go-down


89. Eslami B, Lorente C, Kieff D, Caruso PA, Faquin WC: Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun;105(6):e10-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome.
  • Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by a wide range of clinical signs and symptoms.
  • The major criteria for the diagnosis are multiple cutaneous basal cell carcinomas, multiple odontogenic keratocysts of the jaw, palmar and plantar pits, and skeletal abnormalities.
  • [MeSH-major] Ameloblastoma / etiology. Basal Cell Nevus Syndrome / complications. Jaw Neoplasms / complications. Maxillary Neoplasms / etiology
  • [MeSH-minor] Aged. Chromosomes, Human, Pair 9. Female. Humans. Receptors, Cell Surface / genetics

  • Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18417377.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Cell Surface; 0 / patched receptors
  •  go-up   go-down


90. Park GT, Seo EY, Lee KM, Lee DY, Yang JM: Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes. Br J Dermatol; 2006 Mar;154(3):411-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
  • BACKGROUND: Epidermis consists of multiple layers, from the proliferating basal layer to terminal differentiated cornified layers, and these layers are defined by differentiation status.
  • We evaluated Tob expression in normal skin, oral mucosa and different diseases, such as psoriasis, X-linked ichthyosis and squamous cell carcinoma (SCC).
  • Using immunohistochemical analysis, we observed that Tob was selectively expressed in the basal layer of X-linked ichythyosis and the hyperproliferative basal layer of psoriasis and oral mucosa as well as in normal epidermis.
  • CONCLUSIONS: Tob is stably expressed in primary human keratinocytes and it is specifically expressed in the basal layer of in vivo epidermis.
  • [MeSH-minor] Blotting, Western. Carcinoma, Squamous Cell / metabolism. Cells, Cultured. DNA, Complementary / genetics. Gene Expression. Genetic Markers. Humans. Ichthyosis, X-Linked / metabolism. Immunoenzyme Techniques. Mouth Mucosa / metabolism. Neoplasm Proteins / metabolism. Psoriasis / metabolism. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods. Skin Neoplasms / metabolism. Transfection

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16445768.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / Genetic Markers; 0 / Intracellular Signaling Peptides and Proteins; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / TOB1 protein, human; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


91. Han A, Penrose C, Goldsmith A, Marmur ES: Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments. J Drugs Dermatol; 2010 Jul;9(7):864-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Actinic keratoses are premalignant lesions that increase in frequency with each decade of life and have the potential to progress to squamous cell carcinoma.
  • Non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma, also represent sun-related conditions that require early and aggressive treatment.
  • The following case-based review represents typical situations where multiple treatments were combined to manage actinic keratosis, squamous cell carcinoma and basal cell carcinoma in patients over an extended treatment period.
  • [MeSH-minor] Aged. Aged, 80 and over. Carcinoma, Basal Cell / therapy. Carcinoma, Squamous Cell / therapy. Combined Modality Therapy. Cryotherapy. Female. Humans. Male. Middle Aged. Photochemotherapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677546.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


92. Rigel DS: Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol; 2008 May;58(5 Suppl 2):S129-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple studies have now demonstrated a relationship between ultraviolet exposure and increased risk of developing skin cancer.
  • However, the specifics of that association are somewhat different for malignant melanoma, basal cell carcinoma, and squamous cell carcinoma.
  • [MeSH-minor] Australia / epidemiology. Carcinoma, Basal Cell / epidemiology. Carcinoma, Basal Cell / etiology. Carcinoma, Basal Cell / prevention & control. Carcinoma, Squamous Cell / epidemiology. Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / prevention & control. Humans. Melanoma / epidemiology. Melanoma / etiology. Melanoma / prevention & control. Risk Assessment. Time Factors. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18410798.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 43
  •  go-up   go-down


93. Tévar E, Torrelo A, Contreras F, Colmenero I, Zambrano A: [Multiple basal cell carcinomas on phacomatosis pigmentokeratotica]. Actas Dermosifiliogr; 2006 Oct;97(8):518-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple basal cell carcinomas on phacomatosis pigmentokeratotica].
  • We present a patient with phacomatosis pigmentokeratotica (PPK) who developed several basal cell carcinomas on epidermal nevus lesions in adult life.
  • [MeSH-major] Carcinoma, Basal Cell. Neoplasms, Multiple Primary. Neurocutaneous Syndromes. Skin Neoplasms

  • Genetic Alliance. consumer health - Phacomatosis pigmentokeratotica.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17067530.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] Case Reports; Comparative Study; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


94. Tran KT, Lamb P, Deng JS: Matrikines and matricryptins: Implications for cutaneous cancers and skin repair. J Dermatol Sci; 2005 Oct;40(1):11-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The extracellular matrix plays a pivotal role in cellular migration, proliferation, and gene regulation during wound healing and progression of melanoma, basal cell carcinoma, and squamous cell carcinoma.
  • Within the last few years, a new class of ligand, the matrikine or matricryptin, has been characterized as subdomains of various ECM proteins capable of signaling to the cell through receptors, such as growth factor receptors.
  • Unlike traditional soluble growth factors, most matrikines possess low binding affinity to their receptors and are often presented in multiple valency that likely increase avidity to receptors.
  • [MeSH-minor] Amino Acid Sequence. Animals. Cell Adhesion Molecules / physiology. Collagen / physiology. Humans. Ligands. Molecular Sequence Data. Signal Transduction. Tenascin / physiology. Tissue Engineering. Wound Healing

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15993569.001).
  • [ISSN] 0923-1811
  • [Journal-full-title] Journal of dermatological science
  • [ISO-abbreviation] J. Dermatol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cell Adhesion Molecules; 0 / Extracellular Matrix Proteins; 0 / Ligands; 0 / Tenascin; 0 / kalinin; 9007-34-5 / Collagen
  • [Number-of-references] 50
  •  go-up   go-down


95. De Gabory L, Deminière C, Stoll D: [Immunohistochemistry expression of 3 markers (CEA, UEA-I and Ki-67) in nasal inverted papillomas]. Rev Laryngol Otol Rhinol (Bord); 2008;129(3):159-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This expression was present in the basal cells.
  • However the expression of Ki-67 in more than 50% of the cells involving the full epithelium thickness would seem to suggest a particular cellular behavior Whereas the expression of the protein remains generally confined to the basal and suprabasal layers, a more significant population of Ki-67+ cells disseminated in the epithelium, would signify a tendency of the epithelium to escape the regulation mechanisms.
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Child. Diagnosis, Differential. Ear Neoplasms / pathology. Ear Neoplasms / surgery. Female. Humans. Immunoenzyme Techniques. Male. Middle Aged. Nasal Mucosa / pathology. Nasal Polyps / pathology. Nasal Polyps / surgery. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / surgery. Prognosis. Reference Values

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19694158.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carcinoembryonic Antigen; 0 / Ki-67 Antigen; 0 / Plant Lectins; 0 / Ulex europaeus lectins
  •  go-up   go-down


96. Wick MJ, Blaine S, Van Putten V, Saavedra M, Nemenoff RA: Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter. Biochem J; 2005 Apr 1;387(Pt 1):239-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Increased expression of cPLA2 (cytosolic phospholipase A2) has been shown to be the cause of tumorigenesis of NSCLC (non-small-cell lung cancer).
  • Multiple members of the Krüppel family were identified, with LKLF (lung Krüppel-like factor) being isolated a number of times.
  • Expression of siRNA (small interfering RNA) directed against LKLF inhibited basal expression of cPLA2 in lung epithelial cells and blocked induction by H-Ras.

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Cancer. 2000 Feb;36(3):314-29 [10708932.001]
  • [Cites] Nucleic Acids Res. 1999 Aug 1;27(15):2991-3000 [10454592.001]
  • [Cites] J Biol Chem. 2001 Jan 12;276(2):1226-32 [11042196.001]
  • [Cites] J Clin Pathol. 2001 Apr;54(4):257-71 [11304841.001]
  • [Cites] J Cell Physiol. 2001 Aug;188(2):143-60 [11424081.001]
  • [Cites] J Biol Chem. 2001 Aug 10;276(32):30150-60 [11375391.001]
  • [Cites] J Biol Chem. 2001 Sep 14;276(37):34355-8 [11443140.001]
  • [Cites] J Biol Chem. 2001 Nov 16;276(46):42737-43 [11559711.001]
  • [Cites] Science. 2001 Nov 30;294(5548):1871-5 [11729303.001]
  • [Cites] Oncology (Williston Park). 2002 Feb;16(2):217-26, 229; discussion 230-2 [11866137.001]
  • [Cites] Anticancer Drugs. 2002 Feb;13(2):127-37 [11901304.001]
  • [Cites] Lancet Oncol. 2001 Sep;2(9):544-51 [11905709.001]
  • [Cites] Mol Cell Endocrinol. 2002 Sep 30;195(1-2):27-38 [12354670.001]
  • [Cites] Mol Pharmacol. 2002 Nov;62(5):1207-14 [12391285.001]
  • [Cites] FEBS Lett. 2002 Oct 30;531(1):2-6 [12401193.001]
  • [Cites] Carcinogenesis. 2004 Aug;25(8):1517-24 [15033900.001]
  • [Cites] Cancer Res. 1988 May 15;48(10):2674-7 [3129183.001]
  • [Cites] Cancer Res. 1988 Jun 1;48(11):3140-7 [3130187.001]
  • [Cites] Cancer Res. 1988 Sep 1;48(17):4770-5 [3409218.001]
  • [Cites] J Biol Chem. 1988 Nov 15;263(32):16645-51 [3141409.001]
  • [Cites] Nucleic Acids Res. 1992 Feb 25;20(4):917 [1542585.001]
  • [Cites] J Am Soc Nephrol. 1992 Aug;3(2):128-50 [1391715.001]
  • [Cites] J Biol Chem. 1993 Jan 25;268(3):1960-4 [8380583.001]
  • [Cites] Nature. 1993 Sep 30;365(6445):462-4 [8003102.001]
  • [Cites] Biochim Biophys Acta. 1994 Apr 6;1217(3):345-7 [8148385.001]
  • [Cites] Biochem Biophys Res Commun. 1994 Nov 30;205(1):6-11 [7999086.001]
  • [Cites] Nucleic Acids Res. 1994 Nov 25;22(23):5093-8 [7800505.001]
  • [Cites] Mol Cell Biol. 1995 Nov;15(11):5957-65 [7565748.001]
  • [Cites] Cancer Detect Prev. 1996;20(6):634-7 [8939350.001]
  • [Cites] J Biol Chem. 1996 Dec 6;271(49):31496-501 [8940164.001]
  • [Cites] J Biol Chem. 1997 Apr 11;272(15):10196-204 [9092567.001]
  • [Cites] Carcinogenesis. 1997 May;18(5):1001-6 [9163687.001]
  • [Cites] J Biol Chem. 1997 Jun 6;272(23):14501-4 [9169405.001]
  • [Cites] Science. 1997 Sep 26;277(5334):1986-90 [9302292.001]
  • [Cites] Biochem J. 1997 Nov 1;327 ( Pt 3):709-16 [9581546.001]
  • [Cites] Genes Dev. 1997 Nov 15;11(22):2996-3006 [9367982.001]
  • [Cites] Anticancer Res. 1998 Mar-Apr;18(2A):775-82 [9615719.001]
  • [Cites] J Biol Chem. 1999 Jul 23;274(30):21180-5 [10409672.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2000 Apr;278(4):L649-57 [10749741.001]
  • (PMID = 15540987.001).
  • [ISSN] 1470-8728
  • [Journal-full-title] The Biochemical journal
  • [ISO-abbreviation] Biochem. J.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P50 CA058187; United States / NCI NIH HHS / CA / CA58187; United States / NCI NIH HHS / CA / CA108610; United States / NCI NIH HHS / CA / R01 CA108610; United States / NCI NIH HHS / CA / CA103618; United States / NCI NIH HHS / CA / R01 CA103618
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / KLF2 protein, human; 0 / Kruppel-Like Transcription Factors; 0 / RNA, Small Interfering; 0 / Trans-Activators; EC 3.1.1.- / Phospholipases A; EC 3.1.1.4 / Group IV Phospholipases A2; EC 3.1.1.4 / Phospholipases A2
  • [Other-IDs] NLM/ PMC1134952
  •  go-up   go-down


97. Mougel F, Debarbieux S, Ronger-Savlé S, Dalle S, Thomas L: Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy. Dermatology; 2009;219(2):138-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy.
  • BACKGROUND: The naevoid basal cell carcinoma syndrome (NBCCS) is a therapeutic challenge due to the multiplicity of cutaneous tumours.
  • Photodynamic therapy (PDT) is increasingly used as an alternative treatment for superficial and in some countries nodular basal cell carcinomas (BCC).
  • METHODS: We reviewed retrospectively the evolution of 62 lesions from patients with multiple BCC treated with PDT.
  • [MeSH-major] Aminolevulinic Acid / therapeutic use. Basal Cell Nevus Syndrome / drug therapy. Basal Cell Nevus Syndrome / radiotherapy. Neoplasm Recurrence, Local / pathology. Photochemotherapy / methods. Skin Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19590166.001).
  • [ISSN] 1421-9832
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 88755TAZ87 / Aminolevulinic Acid
  •  go-up   go-down


98. Veness MJ, Harris D: Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol; 2007 Feb;51(1):12-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Organ transplant recipients experience a higher incidence of NMSC when compared with the general population and a higher incidence of squamous cell carcinoma compared with basal cell carcinoma.
  • Organ transplant recipients also develop NMSC at a younger age and experience multiple new NMSC.
  • The emphasis will be on the treatment of patients with a high-risk NMSC (e.g. squamous cell carcinoma, Merkel cell carcinoma, unfavourable basal cell carcinoma) because this reflects the most common clinical scenario in which a recommendation of radiotherapy, usually adjuvant, may be considered.

  • MedlinePlus Health Information. consumer health - Organ Transplantation.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17217484.001).
  • [ISSN] 0004-8461
  • [Journal-full-title] Australasian radiology
  • [ISO-abbreviation] Australas Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 44
  •  go-up   go-down


99. Abbas O, Mahalingam M: Tumor of the follicular infundibulum: an epidermal reaction pattern? Am J Dermatopathol; 2009 Oct;31(7):626-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinically, TFI seems to be slightly more common in men (52% vs. 48%) and more common on the head and neck (around 77%) and presents as plaques (approximately 47%) and as multiple lesions (6%).
  • Of interest, approximately one fourth (25%) were associated with other cutaneous lesions, which included basal cell carcinoma, actinic keratosis, desmoplastic malignant melanoma, junctional melanocytic nevus, tricholemmoma, and epidermal inclusion cyst.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19633534.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


100. Siddiqui MA, Su L, Michael CW, Pu RT: Synchronous ordinary lipoma and spindle-cell lipoma diagnosed by fine needle aspiration. Diagn Cytopathol; 2006 Jun;34(6):455-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous ordinary lipoma and spindle-cell lipoma diagnosed by fine needle aspiration.
  • [MeSH-major] Biopsy, Fine-Needle. Lipoma / pathology. Neoplasms, Multiple Primary / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Aged. Carcinoma, Basal Cell / pathology. Humans. Male. Neck / pathology. Scalp / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16680778.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down






Advertisement